Title - COVID-19 Drug Data in Raw Format
Version 7.2.01 (2020.06.01)
Provided by IDRB   Lab of Innovative Drug Reasearch and Bioinformatics
                   College of Pharmaceutical Sciences
                   Zhejiang University
                   https://idrblab.org/
Any question about data provided here, please contact with:
Dr. Wang (lfwyx@zju.edu.cn) and Dr. Li (lifengcheng@zju.edu.cn)

--------------------------------------------------------------------------------------------------------
Abbreviations:

DRUGNAME	Drug Name
DRUGTYPE	Drug Type
DISEASES	Disease Entry
DRUGSTAT	Drug Status
TARGNAME	Target Name
PCHEMCID	PubChem_CID
HIGHSTAT	Drug Highest Status
HIGHDISE	Disease of Drug Highest Status
--------------------------------------------------------------------------------------------------------

DRUG0233	DRUGNAME	Remdesivir	
DRUG0233	DRUGTYPE	Small molecular drug	
DRUG0233	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0233	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0233	TARGNAME	COVID-19 RNA-directed RNA polymerase (RdRp)	R1AB_SARS2 (RdRp)
DRUG0233	PCHEMCID	CID: 121304016	
			
DRUG0234	DRUGNAME	Favipiravir	
DRUG0234	DRUGTYPE	Small molecular drug	
DRUG0234	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0234	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0234	TARGNAME	COVID-19 RNA-directed RNA polymerase (RdRp)	R1AB_SARS2 (RdRp)
DRUG0234	PCHEMCID	CID: 4424075	
DRUG0234	HIGHSTAT	Approved	
DRUG0234	HIGHDISE	Influenza virus infection	
			
DRUG0191	DRUGNAME	Baricitinib	
DRUG0191	DRUGTYPE	Small molecular drug	
DRUG0191	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0191	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0191	TARGNAME	HUMAN adaptor-associated kinase 1 (AAK1)	AAK1_HUMAN
DRUG0191	TARGNAME	HUMAN cyclin G-associated kinase (GAK)	GAK_HUMAN
DRUG0191	PCHEMCID	CID: 44205240	
DRUG0191	HIGHSTAT	Approved	
DRUG0191	HIGHDISE	Rheumatoid arthritis	
			
DRUG0225	DRUGNAME	Anakinra	
DRUG0225	DRUGTYPE	Small molecular drug	
DRUG0225	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0225	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0225	TARGNAME	HUMAN interleukin-1 receptor 1 (IL1R1)	IL1R1_HUMAN
DRUG0225	PCHEMCID	CID: 139595263	
DRUG0225	HIGHSTAT	Approved	
DRUG0225	HIGHDISE	Rheumatoid arthritis	
			
DRUG0202	DRUGNAME	Ruxolitinib	
DRUG0202	DRUGTYPE	Small molecular drug	
DRUG0202	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0202	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0202	TARGNAME	HUMAN janus kinase 1 (JAK-1)	JAK1_HUMAN
DRUG0202	TARGNAME	HUMAN janus kinase 2 (JAK-2)	JAK2_HUMAN
DRUG0202	PCHEMCID	CID: 25126798	
DRUG0202	HIGHSTAT	Approved	
DRUG0202	HIGHDISE	Myelofibrosis	
			
DRUG0205	DRUGNAME	Isotretinoin	
DRUG0205	DRUGTYPE	Small molecular drug	
DRUG0205	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0205	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0205	TARGNAME	COVID-19 papain-like proteinase (PL-PRO)	R1AB_SARS2 (PL-PRO)
DRUG0205	PCHEMCID	CID: 5282379	
			
DRUG0189	DRUGNAME	IMU-838	
DRUG0189	DRUGTYPE	Small molecular drug	
DRUG0189	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0189	DRUGSTAT	Drug in Phase 2/3 Clinical Trial	
DRUG0189	TARGNAME	HUMAN dihydroorotate dehydrogenase (DHODH)	PYRD_HUMAN
DRUG0189	PCHEMCID	CID: 9820008	
			
DRUG0172	DRUGNAME	Nafamostat	
DRUG0172	DRUGTYPE	Small molecular drug	
DRUG0172	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0172	DRUGSTAT	Drug in Phase 2/3 Clinical Trial	
DRUG0172	TARGNAME	COVID-19 spike glycoprotein (S)	SPIKE_SARS2
DRUG0172	PCHEMCID	CID: 4413	
			
DRUG0242	DRUGNAME	Captopril	
DRUG0242	DRUGTYPE	Small molecular drug	
DRUG0242	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0242	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0242	TARGNAME	HUMAN angiotensin-converting enzyme (ACE)	ACE_HUMAN
DRUG0242	PCHEMCID	CID: 44093	
DRUG0242	HIGHSTAT	Approved	
DRUG0242	HIGHDISE	Hypertension	
			
DRUG0238	DRUGNAME	Telmisartan	
DRUG0238	DRUGTYPE	Small molecular drug	
DRUG0238	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0238	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0238	TARGNAME	HUMAN type-1 angiotensin II receptor (AGTR1)	AGTR1_HUMAN
DRUG0238	PCHEMCID	CID: 65999	
DRUG0238	HIGHSTAT	Approved	
DRUG0238	HIGHDISE	Hypertension	
			
DRUG0239	DRUGNAME	Losartan	
DRUG0239	DRUGTYPE	Small molecular drug	
DRUG0239	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0239	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0239	TARGNAME	HUMAN type-1 angiotensin II receptor (AGTR1)	AGTR1_HUMAN
DRUG0239	PCHEMCID	CID: 3961	
DRUG0239	HIGHSTAT	Approved	
DRUG0239	HIGHDISE	Hypertension	
			
DRUG0245	DRUGNAME	Linagliptin	
DRUG0245	DRUGTYPE	Small molecular drug	
DRUG0245	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0245	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0245	TARGNAME	HUMAN dipeptidyl peptidase 4 (DPP-4)	DPP4_HUMAN
DRUG0245	PCHEMCID	CID: 10096344	
DRUG0245	HIGHSTAT	Approved	
DRUG0245	HIGHDISE	Type 2 diabetes	
			
DRUG0231	DRUGNAME	Sildenafil	
DRUG0231	DRUGTYPE	Small molecular drug	
DRUG0231	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0231	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0231	TARGNAME	HUMAN phosphodiesterase type 5 (PDE5)	PDE5A_HUMAN
DRUG0231	PCHEMCID	CID: 135398744	
DRUG0231	HIGHSTAT	Approved	
DRUG0231	HIGHDISE	Erectile dysfunction	
			
DRUG0185	DRUGNAME	Verapamil	
DRUG0185	DRUGTYPE	Small molecular drug	
DRUG0185	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0185	DRUGSTAT	Drug in Phase 2/3 Clinical Trial	
DRUG0185	TARGNAME	HUMAN two pore channel subtype 2 (TPC2)	TPC2_HUMAN
DRUG0185	PCHEMCID	CID: 2520	
DRUG0185	HIGHSTAT	Approved	
DRUG0185	HIGHDISE	High blood pressure	
			
DRUG0186	DRUGNAME	Amiodarone	
DRUG0186	DRUGTYPE	Small molecular drug	
DRUG0186	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0186	DRUGSTAT	Drug in Phase 2/3 Clinical Trial	
DRUG0186	TARGNAME	HUMAN two pore channel subtype 2 (TPC2)	TPC2_HUMAN
DRUG0186	PCHEMCID	CID: 2157	
DRUG0186	HIGHSTAT	Approved	
DRUG0186	HIGHDISE	Ventricular tachycardia	
			
DRUG0241	DRUGNAME	Ramipril	
DRUG0241	DRUGTYPE	Small molecular drug	
DRUG0241	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0241	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0241	TARGNAME	HUMAN angiotensin-converting enzyme (ACE)	ACE_HUMAN
DRUG0241	PCHEMCID	CID: 5362129	
DRUG0241	HIGHSTAT	Approved	
DRUG0241	HIGHDISE	Heart failure	
			
DRUG0163	DRUGNAME	Acalabrutinib	
DRUG0163	DRUGTYPE	Small molecular drug	
DRUG0163	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0163	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0163	TARGNAME	HUMAN bruton tyrosine kinase (BTK)	BTK_HUMAN
DRUG0163	PCHEMCID	CID: 71226662	
DRUG0163	HIGHSTAT	Approved	
DRUG0163	HIGHDISE	Leukemia	
			
DRUG0156	DRUGNAME	BLD-2660	
DRUG0156	DRUGTYPE	Small molecular drug	
DRUG0156	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0156	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0156	TARGNAME	HUMAN calpain-1/calpain small subunit 1 dimer (CAPN1/CAPNS1)	CAN1_HUMAN/CPNS1_HUMAN
DRUG0156	TARGNAME	HUMAN calpain-2/calpain small subunit 1 dimer (CAPN2/CAPNS1)	CAN2_HUMAN/CPNS1_HUMAN
			
DRUG0169	DRUGNAME	Sirolimus	
DRUG0169	DRUGTYPE	Small molecular drug	
DRUG0169	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0169	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0169	TARGNAME	HUMAN mammalian target of rapamycin (mTOR)	MTOR_HUMAN
DRUG0169	PCHEMCID	CID: 5284616	
DRUG0169	HIGHSTAT	Approved	
DRUG0169	HIGHDISE	Lymphangioleiomyomatosis	
			
DRUG0160	DRUGNAME	Duvelisib	
DRUG0160	DRUGTYPE	Small molecular drug	
DRUG0160	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0160	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0160	TARGNAME	HUMAN PI3-kinase delta (PIK3CD)	PK3CD_HUMAN
DRUG0160	TARGNAME	HUMAN PI3-kinase gamma (PIK3CG)	PK3CG_HUMAN
DRUG0160	PCHEMCID	CID: 50905713	
DRUG0160	HIGHSTAT	Approved	
DRUG0160	HIGHDISE	Follicular lymphoma	
			
DRUG0171	DRUGNAME	Camostat mesylate	
DRUG0171	DRUGTYPE	Small molecular drug	
DRUG0171	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0171	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0171	TARGNAME	HUMAN transmembrane protease serine 2 (TMPRSS2)	TMPS2_HUMAN
DRUG0171	PCHEMCID	CID: 5284360	
			
DRUG0155	DRUGNAME	Rintatolimod	
DRUG0155	DRUGTYPE	Small molecular drug	
DRUG0155	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0155	DRUGSTAT	Drug in Phase 1/2 Clinical Trial	
DRUG0155	TARGNAME	HUMAN toll-like receptor 3 (TLR3)	TLR3_HUMAN
DRUG0155	PCHEMCID	CID: 135537060	
DRUG0155	HIGHSTAT	Phase 3	
DRUG0155	HIGHDISE	Chronic Fatigue Syndrome	
			
DRUG0188	DRUGNAME	Leflunomide	
DRUG0188	DRUGTYPE	Small molecular drug	
DRUG0188	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0188	DRUGSTAT	Drug in Phase 1 Clinical Trial	
DRUG0188	TARGNAME	HUMAN dihydroorotate dehydrogenase (DHODH)	PYRD_HUMAN
DRUG0188	PCHEMCID	CID: 3899	
DRUG0188	HIGHSTAT	Approved	
DRUG0188	HIGHDISE	Multiple sclerosis	
			
DRUG0232	DRUGNAME	Galidesivir	
DRUG0232	DRUGTYPE	Small molecular drug	
DRUG0232	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0232	DRUGSTAT	Drug in Phase 1 Clinical Trial	
DRUG0232	TARGNAME	COVID-19 RNA-directed RNA polymerase (RdRp)	R1AB_SARS2 (RdRp)
DRUG0232	PCHEMCID	CID: 69211190	
			
DRUG0243	DRUGNAME	Lisinopril	
DRUG0243	DRUGTYPE	Small molecular drug	
DRUG0243	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0243	DRUGSTAT	Investigative Agent	
DRUG0243	TARGNAME	HUMAN angiotensin-converting enzyme (ACE)	ACE_HUMAN
DRUG0243	PCHEMCID	CID: 5362119	
DRUG0243	HIGHSTAT	Approved	
DRUG0243	HIGHDISE	Hypertension	
			
DRUG0255	DRUGNAME	Carvedilol	
DRUG0255	DRUGTYPE	Small molecular drug	
DRUG0255	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0255	DRUGSTAT	Investigative Agent	
DRUG0255	TARGNAME	HUMAN beta adrenergic receptor (BAR)	ADRB1_HUMAN; ADRB2_HUMAN; ADRB3_HUMAN
DRUG0255	PCHEMCID	CID: 2585	
DRUG0255	HIGHSTAT	Approved	
DRUG0255	HIGHDISE	Heart failure	
			
DRUG0240	DRUGNAME	Irbesartan	
DRUG0240	DRUGTYPE	Small molecular drug	
DRUG0240	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0240	DRUGSTAT	Investigative Agent	
DRUG0240	TARGNAME	HUMAN type-1 angiotensin II receptor (AGTR1)	AGTR1_HUMAN
DRUG0240	PCHEMCID	CID: 3749	
DRUG0240	HIGHSTAT	Approved	
DRUG0240	HIGHDISE	Hypertension	
			
DRUG0253	DRUGNAME	JQ1	
DRUG0253	DRUGTYPE	Small molecular drug	
DRUG0253	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0253	DRUGSTAT	Investigative Agent	
DRUG0253	TARGNAME	HUMAN bromodomain-containing protein 2 (BRD2)	BRD2_HUMAN
DRUG0253	PCHEMCID	CID: 46907787	
			
DRUG0254	DRUGNAME	ABBV-744	
DRUG0254	DRUGTYPE	Small molecular drug	
DRUG0254	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0254	DRUGSTAT	Investigative Agent	
DRUG0254	TARGNAME	HUMAN bromodomain-containing protein 2 (BRD2)	BRD2_HUMAN
DRUG0254	PCHEMCID	CID: 132010322	
			
DRUG0257	DRUGNAME	Silmitasertib	
DRUG0257	DRUGTYPE	Small molecular drug	
DRUG0257	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0257	DRUGSTAT	Investigative Agent	
DRUG0257	TARGNAME	HUMAN casein kinase II (CSK2)	CSK21_HUMAN; CSK22_HUMAN; CSK23_HUMAN; CSK2B_HUMAN
DRUG0257	PCHEMCID	CID: 24748573	
DRUG0257	HIGHSTAT	Phase 1/2	
DRUG0257	HIGHDISE	Cholangiocarcinoma	
			
DRUG0152	DRUGNAME	Ribavirin	
DRUG0152	DRUGTYPE	Small molecular drug	
DRUG0152	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0152	DRUGSTAT	Investigative Agent	
DRUG0152	TARGNAME	HUMAN inosine-5'-monophosphate dehydrogenase 1 (IMPDH1)	IMDH1_HUMAN
DRUG0152	TARGNAME	HUMAN inosine-5'-monophosphate dehydrogenase 2 (IMPDH2)	IMDH2_HUMAN
DRUG0152	PCHEMCID	CID: 37542	
			
DRUG0251	DRUGNAME	Merimepodib	
DRUG0251	DRUGTYPE	Small molecular drug	
DRUG0251	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0251	DRUGSTAT	Investigative Agent	
DRUG0251	TARGNAME	HUMAN inosine-5'-monophosphate dehydrogenase 2 (IMPDH2)	IMDH2_HUMAN
DRUG0251	PCHEMCID	CID: 153241	
DRUG0251	HIGHSTAT	Phase 2b	
DRUG0251	HIGHDISE	Hepatitis C virus infection	
			
DRUG0214	DRUGNAME	Fedratinib	
DRUG0214	DRUGTYPE	Small molecular drug	
DRUG0214	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0214	DRUGSTAT	Investigative Agent	
DRUG0214	TARGNAME	HUMAN janus kinase 2 (JAK-2)	JAK2_HUMAN
DRUG0214	PCHEMCID	CID: 16722836	
DRUG0214	HIGHSTAT	Approved	
DRUG0214	HIGHDISE	Polycythemia vera	
			
DRUG0252	DRUGNAME	Metformin	
DRUG0252	DRUGTYPE	Small molecular drug	
DRUG0252	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0252	DRUGSTAT	Investigative Agent	
DRUG0252	TARGNAME	HUMAN mannose receptor (MRC1)	MRC1_HUMAN
DRUG0252	PCHEMCID	CID: 4091	
DRUG0252	HIGHSTAT	Approved	
DRUG0252	HIGHDISE	Type 2 diabetes	
			
DRUG0170	DRUGNAME	Sapanisertib	
DRUG0170	DRUGTYPE	Small molecular drug	
DRUG0170	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0170	DRUGSTAT	Investigative Agent	
DRUG0170	TARGNAME	HUMAN mammalian target of rapamycin (mTOR)	MTOR_HUMAN
DRUG0170	PCHEMCID	CID: 45375953	
DRUG0170	HIGHSTAT	Phase 2	
DRUG0170	HIGHDISE	Breast Cancer	
			
DRUG0235	DRUGNAME	Suramin	
DRUG0235	DRUGTYPE	Small molecular drug	
DRUG0235	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0235	DRUGSTAT	Investigative Agent	
DRUG0235	TARGNAME	COVID-19 RNA-directed RNA polymerase (RdRp)	R1AB_SARS2 (RdRp)
DRUG0235	PCHEMCID	CID: 5361	
DRUG0235	HIGHSTAT	Phase 1	
DRUG0235	HIGHDISE	African trypanosomiasis	
			
DRUG0236	DRUGNAME	Penciclovir	
DRUG0236	DRUGTYPE	Small molecular drug	
DRUG0236	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0236	DRUGSTAT	Investigative Agent	
DRUG0236	TARGNAME	COVID-19 RNA-directed RNA polymerase (RdRp)	R1AB_SARS2 (RdRp)
DRUG0236	PCHEMCID	CID: 135398748	
DRUG0236	HIGHSTAT	Approved	
DRUG0236	HIGHDISE	Recurrent herpes labialis	
			
DRUG0237	DRUGNAME	Anidulafungin	
DRUG0237	DRUGTYPE	Small molecular drug	
DRUG0237	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0237	DRUGSTAT	Investigative Agent	
DRUG0237	TARGNAME	COVID-19 RNA-directed RNA polymerase (RdRp)	R1AB_SARS2 (RdRp)
DRUG0237	PCHEMCID	CID: 166548	
DRUG0237	HIGHSTAT	Approved	
DRUG0237	HIGHDISE	Candidiasis	
			
DRUG0206	DRUGNAME	Tideglusib	
DRUG0206	DRUGTYPE	Small molecular drug	
DRUG0206	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0206	DRUGSTAT	Investigative Agent	
DRUG0206	TARGNAME	COVID-19 papain-like proteinase (PL-PRO)	R1AB_SARS2 (PL-PRO)
DRUG0206	PCHEMCID	CID: 11313622	
DRUG0206	HIGHSTAT	Phase 2	
DRUG0206	HIGHDISE	Alzheimer disease	
			
DRUG0207	DRUGNAME	SPI-1005	
DRUG0207	DRUGTYPE	Small molecular drug	
DRUG0207	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0207	DRUGSTAT	Investigative Agent	
DRUG0207	TARGNAME	COVID-19 papain-like proteinase (PL-PRO)	R1AB_SARS2 (PL-PRO)
DRUG0207	PCHEMCID	CID: 3194	
DRUG0207	HIGHSTAT	Phase 2b	
DRUG0207	HIGHDISE	Meniere disease	
			
DRUG0208	DRUGNAME	PX-12	
DRUG0208	DRUGTYPE	Small molecular drug	
DRUG0208	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0208	DRUGSTAT	Investigative Agent	
DRUG0208	TARGNAME	COVID-19 papain-like proteinase (PL-PRO)	R1AB_SARS2 (PL-PRO)
DRUG0208	HIGHSTAT	Phase 2	
DRUG0208	HIGHDISE	Pancreatic cancer	
			
DRUG0209	DRUGNAME	PMID32321856-compound-11b	
DRUG0209	DRUGTYPE	Small molecular drug	
DRUG0209	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0209	DRUGSTAT	Investigative Agent	
DRUG0209	TARGNAME	COVID-19 papain-like proteinase (PL-PRO)	R1AB_SARS2 (PL-PRO)
			
DRUG0210	DRUGNAME	PMID32321856-compound-11a	
DRUG0210	DRUGTYPE	Small molecular drug	
DRUG0210	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0210	DRUGSTAT	Investigative Agent	
DRUG0210	TARGNAME	COVID-19 papain-like proteinase (PL-PRO)	R1AB_SARS2 (PL-PRO)
			
DRUG0176	DRUGNAME	PMID26868298-compound-N3	
DRUG0176	DRUGTYPE	Small molecular drug	
DRUG0176	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0176	DRUGSTAT	Investigative Agent	
DRUG0176	TARGNAME	COVID-19 papain-like proteinase (PL-PRO)	R1AB_SARS2 (PL-PRO)
			
DRUG0211	DRUGNAME	Isoarnebin 4	
DRUG0211	DRUGTYPE	Small molecular drug	
DRUG0211	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0211	DRUGSTAT	Investigative Agent	
DRUG0211	TARGNAME	COVID-19 papain-like proteinase (PL-PRO)	R1AB_SARS2 (PL-PRO)
			
DRUG0212	DRUGNAME	Hexylcarbamoyl fluorouracil	
DRUG0212	DRUGTYPE	Small molecular drug	
DRUG0212	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0212	DRUGSTAT	Investigative Agent	
DRUG0212	TARGNAME	COVID-19 papain-like proteinase (PL-PRO)	R1AB_SARS2 (PL-PRO)
DRUG0212	PCHEMCID	CID: 2577	
			
DRUG0213	DRUGNAME	Disulfiram	
DRUG0213	DRUGTYPE	Small molecular drug	
DRUG0213	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0213	DRUGSTAT	Investigative Agent	
DRUG0213	TARGNAME	COVID-19 papain-like proteinase (PL-PRO)	R1AB_SARS2 (PL-PRO)
DRUG0213	HIGHSTAT	Approved	
DRUG0213	HIGHDISE	Alcohol dependence	
			
DRUG0179	DRUGNAME	GC376	
DRUG0179	DRUGTYPE	Small molecular drug	
DRUG0179	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0179	DRUGSTAT	Investigative Agent	
DRUG0179	TARGNAME	COVID-19 3C-like protease (3CLpro)	R1AB_SARS2 (3CLpro)
DRUG0179	PCHEMCID	CID: 71481119	
			
DRUG0223	DRUGNAME	Boceprevir	
DRUG0223	DRUGTYPE	Small molecular drug	
DRUG0223	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0223	DRUGSTAT	Investigative Agent	
DRUG0223	TARGNAME	COVID-19 3C-like protease (3CLpro)	R1AB_SARS2 (3CLpro)
DRUG0223	PCHEMCID	CID: 10324367	
			
DRUG0260	DRUGNAME	PB28	
DRUG0260	DRUGTYPE	Small molecular drug	
DRUG0260	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0260	DRUGSTAT	Investigative Agent	
DRUG0260	TARGNAME	HUMAN opioid receptor sigma 1 (OPRS1)	SGMR1_HUMAN
DRUG0260	TARGNAME	HUMAN sigma intracellular receptor 2 (TMEM97)	SGMR2_HUMAN
			
DRUG0261	DRUGNAME	Haloperidol	
DRUG0261	DRUGTYPE	Small molecular drug	
DRUG0261	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0261	DRUGSTAT	Investigative Agent	
DRUG0261	TARGNAME	HUMAN opioid receptor sigma 1 (OPRS1)	SGMR1_HUMAN
DRUG0261	TARGNAME	HUMAN sigma intracellular receptor 2 (TMEM97)	SGMR2_HUMAN
DRUG0261	PCHEMCID	CID: 3559	
DRUG0261	HIGHSTAT	Approved	
DRUG0261	HIGHDISE	Schizophrenia	
			
DRUG0258	DRUGNAME	RS-PPCC	
DRUG0258	DRUGTYPE	Small molecular drug	
DRUG0258	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0258	DRUGSTAT	Investigative Agent	
DRUG0258	TARGNAME	HUMAN opioid receptor sigma 1 (OPRS1)	SGMR1_HUMAN
			
DRUG0259	DRUGNAME	PD-144418	
DRUG0259	DRUGTYPE	Small molecular drug	
DRUG0259	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0259	DRUGSTAT	Investigative Agent	
DRUG0259	TARGNAME	HUMAN opioid receptor sigma 1 (OPRS1)	SGMR1_HUMAN
DRUG0259	PCHEMCID	CID: 9817231	
			
DRUG0262	DRUGNAME	E-52862	
DRUG0262	DRUGTYPE	Small molecular drug	
DRUG0262	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0262	DRUGSTAT	Investigative Agent	
DRUG0262	TARGNAME	HUMAN opioid receptor sigma 1 (OPRS1)	SGMR1_HUMAN
DRUG0262	PCHEMCID	CID: 44247568	
			
DRUG0151	DRUGNAME	NMS-873	
DRUG0151	DRUGTYPE	Small molecular drug	
DRUG0151	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0151	DRUGSTAT	Investigative Agent	
DRUG0151	TARGNAME	HUMAN valosin-containing protein p97 (VCP)	TERA_HUMAN
DRUG0151	PCHEMCID	CID: 71521142	
			
DRUG0227	DRUGNAME	Ravulizumab	
DRUG0227	DRUGTYPE	Monoclonal antibody	
DRUG0227	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0227	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0227	TARGNAME	HUMAN complement C5 protein (C5)	CO5_HUMAN
DRUG0227	PCHEMCID	SID: 363669767	
DRUG0227	HIGHSTAT	Approved	
DRUG0227	HIGHDISE	Paroxysmal nocturnal hemoglobinuria	
			
DRUG0230	DRUGNAME	Lenzilumab	
DRUG0230	DRUGTYPE	Monoclonal antibody	
DRUG0230	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0230	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0230	TARGNAME	HUMAN colony-stimulating factor (GM-CSF)	CSF2_HUMAN
DRUG0230	PCHEMCID	SID: 310264716	
			
DRUG0249	DRUGNAME	Siltuximab	
DRUG0249	DRUGTYPE	Monoclonal antibody	
DRUG0249	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0249	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0249	TARGNAME	HUMAN interleukin 6 (IL6)	IL6_HUMAN
DRUG0249	PCHEMCID	SID: 124490409	
DRUG0249	HIGHSTAT	Approved	
DRUG0249	HIGHDISE	Idiopathic multicentric Castleman disease	
			
DRUG0203	DRUGNAME	Tocilizumab	
DRUG0203	DRUGTYPE	Monoclonal antibody	
DRUG0203	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0203	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0203	TARGNAME	HUMAN interleukin-6 receptor (IL6R)	IL6RA_HUMAN; IL6RB_HUMAN
DRUG0203	HIGHSTAT	Approved	
DRUG0203	HIGHDISE	Giant cell arteritis	
			
DRUG0204	DRUGNAME	Sarilumab	
DRUG0204	DRUGTYPE	Monoclonal antibody	
DRUG0204	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0204	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0204	TARGNAME	HUMAN interleukin-6 receptor (IL6R)	IL6RA_HUMAN; IL6RB_HUMAN
DRUG0204	HIGHSTAT	Approved	
DRUG0204	HIGHDISE	Rheumatoid arthritis	
			
DRUG0184	DRUGNAME	IFX-1	
DRUG0184	DRUGTYPE	Monoclonal antibody	
DRUG0184	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0184	DRUGSTAT	Drug in Phase 2/3 Clinical Trial	
DRUG0184	TARGNAME	HUMAN complement C5 alpha (C5A)	CO5_HUMAN (C5A)
DRUG0184	PCHEMCID	CID: 137254326	
			
DRUG0183	DRUGNAME	Emapalumab	
DRUG0183	DRUGTYPE	Monoclonal antibody	
DRUG0183	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0183	DRUGSTAT	Drug in Phase 2/3 Clinical Trial	
DRUG0183	TARGNAME	HUMAN interferon gamma (IFNG)	IFNG_HUMAN
DRUG0183	PCHEMCID	SID: 318164814	
DRUG0183	HIGHSTAT	Approved	
DRUG0183	HIGHDISE	Primary haemophagocytic lymphohistiocytosis	
			
DRUG0248	DRUGNAME	Olokizumab	
DRUG0248	DRUGTYPE	Monoclonal antibody	
DRUG0248	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0248	DRUGSTAT	Drug in Phase 2/3 Clinical Trial	
DRUG0248	TARGNAME	HUMAN interleukin 6 (IL6)	IL6_HUMAN
DRUG0248	PCHEMCID	SID: 160677293	
DRUG0248	HIGHSTAT	Phase 3	
DRUG0248	HIGHDISE	Rheumatoid Arthritis	
			
DRUG0190	DRUGNAME	Bevacizumab	
DRUG0190	DRUGTYPE	Monoclonal antibody	
DRUG0190	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0190	DRUGSTAT	Drug in Phase 2/3 Clinical Trial	
DRUG0190	TARGNAME	HUMAN vascular endothelial growth factor (VEGF)	VEGFA_HUMAN; VEGFB_HUMAN; VEGFC_HUMAN; VEGFD_HUMAN
DRUG0190	HIGHSTAT	Approved	
DRUG0190	HIGHDISE	Metastatic colorectal cancer	
			
DRUG0161	DRUGNAME	LY3127804	
DRUG0161	DRUGTYPE	Monoclonal antibody	
DRUG0161	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0161	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0161	TARGNAME	HUMAN angiopoietin-2 (ANG-2)	ANGP2_HUMAN
			
DRUG0162	DRUGNAME	Avdoralimab	
DRUG0162	DRUGTYPE	Monoclonal antibody	
DRUG0162	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0162	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0162	TARGNAME	HUMAN C5a receptor (C5aR)	C5AR1_HUMAN
			
DRUG0164	DRUGNAME	Leronlimab	
DRUG0164	DRUGTYPE	Monoclonal antibody	
DRUG0164	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0164	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0164	TARGNAME	HUMAN C-C chemokine receptor 5 (CCR5)	CCR5_HUMAN
			
DRUG0226	DRUGNAME	Eculizumab	
DRUG0226	DRUGTYPE	Monoclonal antibody	
DRUG0226	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0226	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0226	TARGNAME	HUMAN complement C5 protein (C5)	CO5_HUMAN
DRUG0226	HIGHSTAT	Approved	
DRUG0226	HIGHDISE	Neuromyelitis optica	
			
DRUG0229	DRUGNAME	Otilimab	
DRUG0229	DRUGTYPE	Monoclonal antibody	
DRUG0229	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0229	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0229	TARGNAME	HUMAN colony-stimulating factor (GM-CSF)	CSF2_HUMAN
DRUG0229	PCHEMCID	SID: 381127828	
DRUG0229	HIGHSTAT	Phase 3	
DRUG0229	HIGHDISE	Rheumatoid arthritis	
			
DRUG0246	DRUGNAME	Sirukumab	
DRUG0246	DRUGTYPE	Monoclonal antibody	
DRUG0246	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0246	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0246	TARGNAME	HUMAN interleukin 6 (IL6)	IL6_HUMAN
DRUG0246	PCHEMCID	SID: 135626800	
DRUG0246	HIGHSTAT	Phase 3	
DRUG0246	HIGHDISE	Rheumatoid arthritis	
			
DRUG0247	DRUGNAME	Clazakizumab	
DRUG0247	DRUGTYPE	Monoclonal antibody	
DRUG0247	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0247	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0247	TARGNAME	HUMAN interleukin 6 (IL6)	IL6_HUMAN
DRUG0247	PCHEMCID	SID: 160671637	
			
DRUG0159	DRUGNAME	BMS-986253	
DRUG0159	DRUGTYPE	Monoclonal antibody	
DRUG0159	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0159	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0159	TARGNAME	HUMAN interleukin 8 (IL8)	IL8_HUMAN
DRUG0159	PCHEMCID	SID: 385157372	
			
DRUG0153	DRUGNAME	Meplazumab	
DRUG0153	DRUGTYPE	Monoclonal antibody	
DRUG0153	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0153	DRUGSTAT	Drug in Phase 1/2 Clinical Trial	
DRUG0153	TARGNAME	HUMAN basigin (BSG)	BASI_HUMAN
			
DRUG0228	DRUGNAME	TJ003234	
DRUG0228	DRUGTYPE	Monoclonal antibody	
DRUG0228	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0228	DRUGSTAT	Drug in Phase 1/2 Clinical Trial	
DRUG0228	TARGNAME	HUMAN colony-stimulating factor (GM-CSF)	CSF2_HUMAN
			
DRUG0166	DRUGNAME	rhACE2	
DRUG0166	DRUGTYPE	Protein/peptide drug	
DRUG0166	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0166	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0166	TARGNAME	HUMAN angiotensin-converting enzyme 2 (ACE2)	ACE2_HUMAN
			
DRUG0157	DRUGNAME	PUL-042	
DRUG0157	DRUGTYPE	Protein/peptide drug	
DRUG0157	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0157	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0157	TARGNAME	HUMAN toll-like receptor 2 (TLR2)	TLR2_HUMAN
DRUG0157	TARGNAME	HUMAN toll-like receptor 6 (TLR6)	TLR6_HUMAN
DRUG0157	TARGNAME	HUMAN toll-like receptor 9 (TLR9)	TLR9_HUMAN
			
DRUG0218	DRUGNAME	Lopinavir + ritonavir + oseltamivir	
DRUG0218	DRUGTYPE	Combination drug	
DRUG0218	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0218	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0218	TARGNAME	COVID-19 3C-like protease (3CLpro)	R1AB_SARS2 (3CLpro)
			
DRUG0219	DRUGNAME	Lopinavir + ritonavir + favipiravir	
DRUG0219	DRUGTYPE	Combination drug	
DRUG0219	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0219	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0219	TARGNAME	COVID-19 3C-like protease (3CLpro)	R1AB_SARS2 (3CLpro)
			
DRUG0220	DRUGNAME	Lopinavir + ritonavir	
DRUG0220	DRUGTYPE	Combination drug	
DRUG0220	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0220	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0220	TARGNAME	COVID-19 3C-like protease (3CLpro)	R1AB_SARS2 (3CLpro)
DRUG0220	PCHEMCID	CID: 11979606	
DRUG0220	HIGHSTAT	Approved	
DRUG0220	HIGHDISE	Human immunodeficiency virus infection	
			
DRUG0221	DRUGNAME	Darunavir + cobicistat	
DRUG0221	DRUGTYPE	Combination drug	
DRUG0221	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0221	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0221	TARGNAME	COVID-19 3C-like protease (3CLpro)	R1AB_SARS2 (3CLpro)
			
DRUG0222	DRUGNAME	ASC09 + ritonavir + oseltamivir	
DRUG0222	DRUGTYPE	Combination drug	
DRUG0222	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0222	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0222	TARGNAME	COVID-19 3C-like protease (3CLpro)	R1AB_SARS2 (3CLpro)
			
DRUG0217	DRUGNAME	Lopinavir + ritonavir + ribavirin + interferon beta-1b	
DRUG0217	DRUGTYPE	Combination drug	
DRUG0217	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0217	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0217	TARGNAME	COVID-19 RNA-directed RNA polymerase (RdRp)	R1AB_SARS2 (RdRp)
DRUG0217	TARGNAME	COVID-19 3C-like protease (3CLpro)	R1AB_SARS2 (3CLpro)
			
DRUG0215	DRUGNAME	Lopinavir + ritonavir + interferon apha + traditional Chinese Medicines granules	
DRUG0215	DRUGTYPE	Combination drug	
DRUG0215	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0215	DRUGSTAT	Drug in Phase 1 Clinical Trial	
DRUG0215	TARGNAME	COVID-19 3C-like protease (3CLpro)	R1AB_SARS2 (3CLpro)
			
DRUG0216	DRUGNAME	ASC09 + ritonavir	
DRUG0216	DRUGTYPE	Combination drug	
DRUG0216	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0216	DRUGSTAT	Drug in Phase 1 Clinical Trial	
DRUG0216	TARGNAME	COVID-19 3C-like protease (3CLpro)	R1AB_SARS2 (3CLpro)
			
DRUG0224	DRUGNAME	Lopinavir + ritonavir + interferon alpha	
DRUG0224	DRUGTYPE	Combination drug	
DRUG0224	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0224	DRUGSTAT	Preclinical Drug	
DRUG0224	TARGNAME	COVID-19 3C-like protease (3CLpro)	R1AB_SARS2 (3CLpro)
			
DRUG0192	DRUGNAME	Hydroxychloroquine	
DRUG0192	DRUGTYPE	Small molecular drug	
DRUG0192	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0192	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0192	TARGNAME	HUMAN toll-like receptor 7/9 signalling pathways (TLR7/9 pathway)	N.A.
DRUG0192	TARGNAME	HUMAN pH-dependent viral fusion/replication (pH-DVF/R)	N.A.
DRUG0192	TARGNAME	HUMAN glycosylation of host receptor (GHR)	N.A.
DRUG0192	PCHEMCID	CID: 3652	
DRUG0192	HIGHSTAT	Approved	
DRUG0192	HIGHDISE	Malaria	
			
DRUG0199	DRUGNAME	Chlorpromazine	
DRUG0199	DRUGTYPE	Small molecular drug	
DRUG0199	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0199	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0199	TARGNAME	HUMAN clathrin-mediated endocytosis (RME)	N.A.
DRUG0199	PCHEMCID	CID: 2726	
DRUG0199	HIGHSTAT	Withdrawn from market	
DRUG0199	HIGHDISE	Schizophrenia	
			
DRUG0010	DRUGNAME	Chloroquine	
DRUG0010	DRUGTYPE	Small molecular drug	
DRUG0010	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0010	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0010	TARGNAME	HUMAN pH-dependent viral fusion/replication (pH-DVF/R)	N.A.
DRUG0010	TARGNAME	HUMAN glycosylation of host receptor (GHR)	N.A.
DRUG0010	PCHEMCID	CID: 2719	
DRUG0010	HIGHSTAT	Withdrawn from market	
DRUG0010	HIGHDISE	Malaria	
			
DRUG0158	DRUGNAME	Atorvastatin	
DRUG0158	DRUGTYPE	Small molecular drug	
DRUG0158	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0158	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0158	TARGNAME	HUMAN MYD88-NF-kappa-B proinflammatory pathway (MYD88-NFKB pathway)	N.A.
DRUG0158	PCHEMCID	CID: 60823	
DRUG0158	HIGHSTAT	Approved	
DRUG0158	HIGHDISE	Hyperlipidemia	
			
DRUG0193	DRUGNAME	Oseltamivir + hydroxychloroquine	
DRUG0193	DRUGTYPE	Combination drug	
DRUG0193	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0193	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0193	TARGNAME	HUMAN toll-like receptor 7/9 signalling pathways (TLR7/9 pathway)	N.A.
DRUG0193	TARGNAME	HUMAN pH-dependent viral fusion/replication (pH-DVF/R)	N.A.
DRUG0193	TARGNAME	HUMAN glycosylation of host receptor (GHR)	N.A.
			
DRUG0194	DRUGNAME	Darunavir + ritonavir + oseltamivir + hydroxychloroquine	
DRUG0194	DRUGTYPE	Combination drug	
DRUG0194	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0194	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0194	TARGNAME	HUMAN toll-like receptor 7/9 signalling pathways (TLR7/9 pathway)	N.A.
DRUG0194	TARGNAME	HUMAN pH-dependent viral fusion/replication (pH-DVF/R)	N.A.
DRUG0194	TARGNAME	HUMAN glycosylation of host receptor (GHR)	N.A.
			
DRUG0195	DRUGNAME	Darunavir + ritonavir + favipiravir + hydroxychloroquine	
DRUG0195	DRUGTYPE	Combination drug	
DRUG0195	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0195	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0195	TARGNAME	HUMAN toll-like receptor 7/9 signalling pathways (TLR7/9 pathway)	N.A.
DRUG0195	TARGNAME	HUMAN pH-dependent viral fusion/replication (pH-DVF/R)	N.A.
DRUG0195	TARGNAME	HUMAN glycosylation of host receptor (GHR)	N.A.
			
DRUG0196	DRUGNAME	Azithromycin + hydroxychloroquine	
DRUG0196	DRUGTYPE	Combination drug	
DRUG0196	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0196	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0196	TARGNAME	HUMAN toll-like receptor 7/9 signalling pathways (TLR7/9 pathway)	N.A.
DRUG0196	TARGNAME	HUMAN pH-dependent viral fusion/replication (pH-DVF/R)	N.A.
DRUG0196	TARGNAME	HUMAN glycosylation of host receptor (GHR)	N.A.
			
DRUG0172	DRUGNAME	Nafamostat	
DRUG0172	DRUGTYPE	Small molecular drug	
DRUG0172	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0172	DRUGSTAT	Preclinical Drug	
DRUG0172	TARGNAME	MERS-CoV spike glycoprotein (S)	A0A140AYZ5_9BETC
DRUG0172	PCHEMCID	CID: 4413	
			
DRUG0302	DRUGNAME	PMID26868298-compound-5705213	
DRUG0302	DRUGTYPE	Small molecular drug	
DRUG0302	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0302	DRUGSTAT	Preclinical Drug	
DRUG0302	TARGNAME	HUMAN cathepsin L (CTSL)	CATL1_HUMAN
			
DRUG0303	DRUGNAME	K11777	
DRUG0303	DRUGTYPE	Small molecular drug	
DRUG0303	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0303	DRUGSTAT	Preclinical Drug	
DRUG0303	TARGNAME	HUMAN cathepsin L (CTSL)	CATL1_HUMAN
			
DRUG0301	DRUGNAME	E-64D	
DRUG0301	DRUGTYPE	Small molecular drug	
DRUG0301	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0301	DRUGSTAT	Preclinical Drug	
DRUG0301	TARGNAME	HUMAN cathepsin L (CTSL)	CATL1_HUMAN
DRUG0301	PCHEMCID	CID: 65663	
			
DRUG0187	DRUGNAME	FA-613	
DRUG0187	DRUGTYPE	Small molecular drug	
DRUG0187	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0187	DRUGSTAT	Preclinical Drug	
DRUG0187	TARGNAME	HUMAN dihydroorotate dehydrogenase (DHODH)	PYRD_HUMAN
			
DRUG0289	DRUGNAME	PMID26048809-compound2	
DRUG0289	DRUGTYPE	Small molecular drug	
DRUG0289	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0289	DRUGSTAT	Preclinical Drug	
DRUG0289	TARGNAME	MERS-CoV RNA-directed RNA polymerase (RdRp)	R1AB_CVEMC (RdRp)
			
DRUG0232	DRUGNAME	Galidesivir	
DRUG0232	DRUGTYPE	Small molecular drug	
DRUG0232	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0232	DRUGSTAT	Preclinical Drug	
DRUG0232	TARGNAME	MERS-CoV RNA-directed RNA polymerase (RdRp)	R1AB_CVEMC (RdRp)
DRUG0232	PCHEMCID	CID: 69211190	
			
DRUG0290	DRUGNAME	PMID31244113-compound-2c	
DRUG0290	DRUGTYPE	Small molecular drug	
DRUG0290	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0290	DRUGSTAT	Preclinical Drug	
DRUG0290	TARGNAME	MERS-CoV RNA-directed RNA polymerase (RdRp)	R1AB_CVEMC (RdRp)
			
DRUG0271	DRUGNAME	Thioguanine	
DRUG0271	DRUGTYPE	Small molecular drug	
DRUG0271	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0271	DRUGSTAT	Preclinical Drug	
DRUG0271	TARGNAME	MERS-CoV papain-like proteinase (PL-PRO)	R1AB_CVEMC (PL-PRO)
DRUG0271	PCHEMCID	CID: 2723601	
DRUG0271	HIGHSTAT	Approved	
DRUG0271	HIGHDISE	Acute lymphocytic leukaemia	
			
DRUG0272	DRUGNAME	Mercaptopurine	
DRUG0272	DRUGTYPE	Small molecular drug	
DRUG0272	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0272	DRUGSTAT	Preclinical Drug	
DRUG0272	TARGNAME	MERS-CoV papain-like proteinase (PL-PRO)	R1AB_CVEMC (PL-PRO)
DRUG0272	PCHEMCID	CID: 667490	
DRUG0272	HIGHSTAT	Approved	
DRUG0272	HIGHDISE	Acute lymphocytic leukaemia	
			
DRUG0273	DRUGNAME	PMID30940566-compound-6	
DRUG0273	DRUGTYPE	Small molecular drug	
DRUG0273	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0273	DRUGSTAT	Preclinical Drug	
DRUG0273	TARGNAME	MERS-CoV papain-like proteinase (PL-PRO)	R1AB_CVEMC (PL-PRO)
			
DRUG0283	DRUGNAME	SSYA10-001	
DRUG0283	DRUGTYPE	Small molecular drug	
DRUG0283	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0283	DRUGSTAT	Preclinical Drug	
DRUG0283	TARGNAME	MERS-CoV helicase (Hel)	R1AB_CVEMC (Hel)
			
DRUG0284	DRUGNAME	PMID31955138-compound-16	
DRUG0284	DRUGTYPE	Small molecular drug	
DRUG0284	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0284	DRUGSTAT	Preclinical Drug	
DRUG0284	TARGNAME	MERS-CoV helicase (Hel)	R1AB_CVEMC (Hel)
			
DRUG0176	DRUGNAME	PMID26868298-compound-N3	
DRUG0176	DRUGTYPE	Small molecular drug	
DRUG0176	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0176	DRUGSTAT	Preclinical Drug	
DRUG0176	TARGNAME	MERS-CoV 3C-like proteinase (3CLpro)	R1AB_CVEMC (3CLpro)
			
DRUG0177	DRUGNAME	GRL-001	
DRUG0177	DRUGTYPE	Small molecular drug	
DRUG0177	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0177	DRUGSTAT	Preclinical Drug	
DRUG0177	TARGNAME	MERS-CoV 3C-like proteinase (3CLpro)	R1AB_CVEMC (3CLpro)
			
DRUG0178	DRUGNAME	Lopinavir	
DRUG0178	DRUGTYPE	Small molecular drug	
DRUG0178	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0178	DRUGSTAT	Preclinical Drug	
DRUG0178	TARGNAME	MERS-CoV 3C-like proteinase (3CLpro)	R1AB_CVEMC (3CLpro)
DRUG0178	PCHEMCID	CID: 92727	
DRUG0178	HIGHSTAT	Approved	
DRUG0178	HIGHDISE	Human immunodeficiency virus infection	
			
DRUG0179	DRUGNAME	GC376	
DRUG0179	DRUGTYPE	Small molecular drug	
DRUG0179	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0179	DRUGSTAT	Preclinical Drug	
DRUG0179	TARGNAME	MERS-CoV 3C-like proteinase (3CLpro)	R1AB_CVEMC (3CLpro)
DRUG0179	PCHEMCID	CID: 71481119	
			
DRUG0180	DRUGNAME	PMID27240464-compound-3f	
DRUG0180	DRUGTYPE	Small molecular drug	
DRUG0180	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0180	DRUGSTAT	Preclinical Drug	
DRUG0180	TARGNAME	MERS-CoV 3C-like proteinase (3CLpro)	R1AB_CVEMC (3CLpro)
			
DRUG0181	DRUGNAME	PMID28216367-compound-6d	
DRUG0181	DRUGTYPE	Small molecular drug	
DRUG0181	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0181	DRUGSTAT	Preclinical Drug	
DRUG0181	TARGNAME	MERS-CoV 3C-like proteinase (3CLpro)	R1AB_CVEMC (3CLpro)
			
DRUG0182	DRUGNAME	GC813	
DRUG0182	DRUGTYPE	Small molecular drug	
DRUG0182	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0182	DRUGSTAT	Preclinical Drug	
DRUG0182	TARGNAME	MERS-CoV 3C-like proteinase (3CLpro)	R1AB_CVEMC (3CLpro)
			
DRUG0268	DRUGNAME	Acocantherin	
DRUG0268	DRUGTYPE	Small molecular drug	
DRUG0268	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0268	DRUGSTAT	Investigative Agent	
DRUG0268	TARGNAME	HUMAN sodium pump subunit alpha-1 (ATP1A1)	AT1A1_HUMAN
DRUG0268	PCHEMCID	CID: 439501	
			
DRUG0125	DRUGNAME	Imatinib	
DRUG0125	DRUGTYPE	Small molecular drug	
DRUG0125	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0125	DRUGSTAT	Investigative Agent	
DRUG0125	TARGNAME	HUMAN fusion protein Bcr-Abl (Bcr-Abl)	BCR_HUMAN-ABL1_HUMAN
DRUG0125	PCHEMCID	CID: 5291	
DRUG0125	HIGHSTAT	Approved	
DRUG0125	HIGHDISE	Chronic myeloid leukaemia	
			
DRUG0267	DRUGNAME	Dasatinib	
DRUG0267	DRUGTYPE	Small molecular drug	
DRUG0267	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0267	DRUGSTAT	Investigative Agent	
DRUG0267	TARGNAME	HUMAN fusion protein Bcr-Abl (Bcr-Abl)	BCR_HUMAN-ABL1_HUMAN
DRUG0267	PCHEMCID	CID: 3062316	
DRUG0267	HIGHSTAT	Approved	
DRUG0267	HIGHDISE	Chronic myeloid leukaemia	
			
DRUG0256	DRUGNAME	Silvestrol	
DRUG0256	DRUGTYPE	Small molecular drug	
DRUG0256	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0256	DRUGSTAT	Investigative Agent	
DRUG0256	TARGNAME	HUMAN eukaryotic initiation factor-4A (eIF4A)	IF4A1_HUMAN; IF4A2_HUMAN; IF4A3_HUMAN
DRUG0256	PCHEMCID	CID: 11787114	
			
DRUG0266	DRUGNAME	Trametinib	
DRUG0266	DRUGTYPE	Small molecular drug	
DRUG0266	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0266	DRUGSTAT	Investigative Agent	
DRUG0266	TARGNAME	HUMAN ERK activator kinase 1 (MEK1)	MP2K1_HUMAN
DRUG0266	TARGNAME	HUMAN ERK activator kinase 2 (MEK2)	MP2K2_HUMAN
DRUG0266	PCHEMCID	CID: 11707110	
DRUG0266	HIGHSTAT	Approved	
DRUG0266	HIGHDISE	Metastatic melanoma	
			
DRUG0265	DRUGNAME	Selumetinib	
DRUG0265	DRUGTYPE	Small molecular drug	
DRUG0265	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0265	DRUGSTAT	Investigative Agent	
DRUG0265	TARGNAME	HUMAN ERK activator kinase 1 (MEK1)	MP2K1_HUMAN
DRUG0265	TARGNAME	HUMAN ERK activator kinase 2 (MEK2)	MP2K2_HUMAN
DRUG0265	PCHEMCID	CID: 10127622	
DRUG0265	HIGHSTAT	Approved	
DRUG0265	HIGHDISE	Neurofibromatosis type 1	
			
DRUG0167	DRUGNAME	Rapamycin	
DRUG0167	DRUGTYPE	Small molecular drug	
DRUG0167	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0167	DRUGSTAT	Investigative Agent	
DRUG0167	TARGNAME	HUMAN mammalian target of rapamycin (mTOR)	MTOR_HUMAN
DRUG0167	PCHEMCID	CID: 6436030	
DRUG0167	HIGHSTAT	Approved	
DRUG0167	HIGHDISE	Lymphangioleiomyomatosis	
			
DRUG0168	DRUGNAME	Everolimus	
DRUG0168	DRUGTYPE	Small molecular drug	
DRUG0168	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0168	DRUGSTAT	Investigative Agent	
DRUG0168	TARGNAME	HUMAN mammalian target of rapamycin (mTOR)	MTOR_HUMAN
DRUG0168	PCHEMCID	CID: 6442177	
DRUG0168	HIGHSTAT	Approved	
DRUG0168	HIGHDISE	Advanced/metastatic breast cancer	
			
DRUG0152	DRUGNAME	Ribavirin	
DRUG0152	DRUGTYPE	Small molecular drug	
DRUG0152	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0152	DRUGSTAT	Investigative Agent	
DRUG0152	TARGNAME	MERS-CoV RNA-directed RNA polymerase (RdRp)	R1AB_CVEMC (RdRp)
DRUG0152	PCHEMCID	CID: 37542	
DRUG0152	HIGHSTAT	Approved	
DRUG0152	HIGHDISE	Hepatitis C virus infection	
			
DRUG0285	DRUGNAME	Amarylline	
DRUG0285	DRUGTYPE	Small molecular drug	
DRUG0285	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0285	DRUGSTAT	Investigative Agent	
DRUG0285	TARGNAME	MERS-CoV RNA-directed RNA polymerase (RdRp)	R1AB_CVEMC (RdRp)
DRUG0285	PCHEMCID	CID: 72378	
			
DRUG0233	DRUGNAME	Remdesivir	
DRUG0233	DRUGTYPE	Small molecular drug	
DRUG0233	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0233	DRUGSTAT	Investigative Agent	
DRUG0233	TARGNAME	MERS-CoV RNA-directed RNA polymerase (RdRp)	R1AB_CVEMC (RdRp)
DRUG0233	PCHEMCID	CID: 121304016	
			
DRUG0270	DRUGNAME	Mycophenolic acid	
DRUG0270	DRUGTYPE	Small molecular drug	
DRUG0270	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0270	DRUGSTAT	Investigative Agent	
DRUG0270	TARGNAME	MERS-CoV papain-like proteinase (PL-PRO)	R1AB_CVEMC (PL-PRO)
DRUG0270	PCHEMCID	CID: 446541	
DRUG0270	HIGHSTAT	Approved	
DRUG0270	HIGHDISE	Crohn disease	
			
DRUG0213	DRUGNAME	Disulfiram	
DRUG0213	DRUGTYPE	Small molecular drug	
DRUG0213	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0213	DRUGSTAT	Investigative Agent	
DRUG0213	TARGNAME	MERS-CoV papain-like proteinase (PL-PRO)	R1AB_CVEMC (PL-PRO)
DRUG0213	PCHEMCID	CID: 3117	
DRUG0213	HIGHSTAT	Approved	
DRUG0213	HIGHDISE	Alcohol dependence	
			
DRUG0154	DRUGNAME	Polyinosinic:polycytidylic acid	
DRUG0154	DRUGTYPE	Small molecular drug	
DRUG0154	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0154	DRUGSTAT	Investigative Agent	
DRUG0154	TARGNAME	HUMAN toll-like receptor 3 (TLR3)	TLR3_HUMAN
DRUG0154	PCHEMCID	CID: 135478809	
			
DRUG0171	DRUGNAME	Camostat mesylate	
DRUG0171	DRUGTYPE	Small molecular drug	
DRUG0171	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0171	DRUGSTAT	Investigative Agent	
DRUG0171	TARGNAME	HUMAN transmembrane protease serine 2 (TMPRSS2)	TMPS2_HUMAN
DRUG0171	PCHEMCID	CID: 5284360	
			
DRUG0244	DRUGNAME	YS110 mAb clone	
DRUG0244	DRUGTYPE	Monoclonal antibody	
DRUG0244	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0244	DRUGSTAT	Investigative Agent	
DRUG0244	TARGNAME	HUMAN dipeptidyl peptidase 4 (DPP-4)	DPP4_HUMAN
			
DRUG0274	DRUGNAME	REGN 3048	
DRUG0274	DRUGTYPE	Monoclonal antibody	
DRUG0274	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0274	DRUGSTAT	Discontinue Drug in Phase 1 Clinical Trial	
DRUG0274	TARGNAME	MERS-CoV spike glycoprotein (S)	A0A140AYZ5_9BETC
			
DRUG0275	DRUGNAME	REGN 3051	
DRUG0275	DRUGTYPE	Monoclonal antibody	
DRUG0275	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0275	DRUGSTAT	Discontinue Drug in Phase 1 Clinical Trial	
DRUG0275	TARGNAME	MERS-CoV spike glycoprotein (S)	A0A140AYZ5_9BETC
			
DRUG0297	DRUGNAME	HR2P-M2 peptide	
DRUG0297	DRUGTYPE	Protein/peptide drug	
DRUG0297	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0297	DRUGSTAT	Preclinical Drug	
DRUG0297	TARGNAME	MERS-CoV spike glycoprotein S2 subunit (S S2)	A0A140AYZ5_9BETC (S2)
			
DRUG0298	DRUGNAME	HR2P peptide	
DRUG0298	DRUGTYPE	Protein/peptide drug	
DRUG0298	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0298	DRUGSTAT	Preclinical Drug	
DRUG0298	TARGNAME	MERS-CoV spike glycoprotein S2 subunit (S S2)	A0A140AYZ5_9BETC (S2)
			
DRUG0299	DRUGNAME	HR1P peptide	
DRUG0299	DRUGTYPE	Protein/peptide drug	
DRUG0299	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0299	DRUGSTAT	Preclinical Drug	
DRUG0299	TARGNAME	MERS-CoV spike glycoprotein S2 subunit (S S2)	A0A140AYZ5_9BETC (S2)
			
DRUG0300	DRUGNAME	HR2P-M1 peptide	
DRUG0300	DRUGTYPE	Protein/peptide drug	
DRUG0300	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0300	DRUGSTAT	Preclinical Drug	
DRUG0300	TARGNAME	MERS-CoV spike glycoprotein S2 subunit (S S2)	A0A140AYZ5_9BETC (S2)
			
DRUG0276	DRUGNAME	PMID26911565-peptide-P9	
DRUG0276	DRUGTYPE	Protein/peptide drug	
DRUG0276	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0276	DRUGSTAT	Preclinical Drug	
DRUG0276	TARGNAME	MERS-CoV spike glycoprotein (S)	A0A140AYZ5_9BETC
			
DRUG0277	DRUGNAME	MERS-five-helix bundle	
DRUG0277	DRUGTYPE	Protein/peptide drug	
DRUG0277	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0277	DRUGSTAT	Preclinical Drug	
DRUG0277	TARGNAME	MERS-CoV spike glycoprotein (S)	A0A140AYZ5_9BETC
			
DRUG0278	DRUGNAME	Peptide P21S10	
DRUG0278	DRUGTYPE	Protein/peptide drug	
DRUG0278	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0278	DRUGSTAT	Preclinical Drug	
DRUG0278	TARGNAME	MERS-CoV spike glycoprotein (S)	A0A140AYZ5_9BETC
			
DRUG0279	DRUGNAME	Alpha-Helical lipopeptides LLS	
DRUG0279	DRUGTYPE	Protein/peptide drug	
DRUG0279	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0279	DRUGSTAT	Preclinical Drug	
DRUG0279	TARGNAME	MERS-CoV spike glycoprotein (S)	A0A140AYZ5_9BETC
			
DRUG0280	DRUGNAME	Alpha-Helical lipopeptides IIS	
DRUG0280	DRUGTYPE	Protein/peptide drug	
DRUG0280	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0280	DRUGSTAT	Preclinical Drug	
DRUG0280	TARGNAME	MERS-CoV spike glycoprotein (S)	A0A140AYZ5_9BETC
			
DRUG0281	DRUGNAME	Alpha-Helical lipopeptides IIK	
DRUG0281	DRUGTYPE	Protein/peptide drug	
DRUG0281	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0281	DRUGSTAT	Preclinical Drug	
DRUG0281	TARGNAME	MERS-CoV spike glycoprotein (S)	A0A140AYZ5_9BETC
			
DRUG0282	DRUGNAME	Alpha-Helical lipopeptides FFS	
DRUG0282	DRUGTYPE	Protein/peptide drug	
DRUG0282	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0282	DRUGSTAT	Preclinical Drug	
DRUG0282	TARGNAME	MERS-CoV spike glycoprotein (S)	A0A140AYZ5_9BETC
			
DRUG0304	DRUGNAME	Dec-RVKR-CMK	
DRUG0304	DRUGTYPE	Protein/peptide drug	
DRUG0304	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0304	DRUGSTAT	Preclinical Drug	
DRUG0304	TARGNAME	HUMAN dibasic-processing enzyme (Furin)	FURIN_HUMAN
DRUG0304	PCHEMCID	CID: 9962075	
			
DRUG0250	DRUGNAME	Fusion peptide EK1	
DRUG0250	DRUGTYPE	Protein/peptide drug	
DRUG0250	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0250	DRUGSTAT	Investigative Agent	
DRUG0250	TARGNAME	MERS-CoV spike glycoprotein S2' HR1 region (S S2'HR1)	A0A140AYZ5_9BETC (S2'HR1)
			
DRUG0264	DRUGNAME	Alisporivir	
DRUG0264	DRUGTYPE	Protein/peptide drug	
DRUG0264	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0264	DRUGSTAT	Investigative Agent	
DRUG0264	TARGNAME	HUMAN cyclophilin A (CYPA)	PPIA_HUMAN
DRUG0264	PCHEMCID	CID: 11513676	
DRUG0264	HIGHSTAT	Phase 3	
DRUG0264	HIGHDISE	Hepatitis C virus infection	
			
DRUG0263	DRUGNAME	Ciclosporin	
DRUG0263	DRUGTYPE	Protein/peptide drug	
DRUG0263	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0263	DRUGSTAT	Investigative Agent	
DRUG0263	TARGNAME	HUMAN cyclophilin D (CYP3)	PPIF_HUMAN
DRUG0263	PCHEMCID	CID: 24883466	
DRUG0263	HIGHSTAT	Approved	
DRUG0263	HIGHDISE	Graft-versus-host disease	
			
DRUG0173	DRUGNAME	Lopinavir + ritonavir + interferon beta-1b	
DRUG0173	DRUGTYPE	Combination drug	
DRUG0173	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0173	DRUGSTAT	Drug in Phase 2/3 Clinical Trial	
DRUG0173	TARGNAME	MERS-CoV 3C-like proteinase (3CLpro)	R1AB_CVEMC (3CLpro)
			
DRUG0286	DRUGNAME	Ribavirin + interferon alfa-2a	
DRUG0286	DRUGTYPE	Combination drug	
DRUG0286	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0286	DRUGSTAT	Investigative Agent	
DRUG0286	TARGNAME	MERS-CoV RNA-directed RNA polymerase (RdRp)	R1AB_CVEMC (RdRp)
			
DRUG0287	DRUGNAME	Ribavirin + interferon alfa-2b	
DRUG0287	DRUGTYPE	Combination drug	
DRUG0287	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0287	DRUGSTAT	Investigative Agent	
DRUG0287	TARGNAME	MERS-CoV RNA-directed RNA polymerase (RdRp)	R1AB_CVEMC (RdRp)
			
DRUG0288	DRUGNAME	Ribavirin + interferon beta-1a	
DRUG0288	DRUGTYPE	Combination drug	
DRUG0288	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0288	DRUGSTAT	Investigative Agent	
DRUG0288	TARGNAME	MERS-CoV RNA-directed RNA polymerase (RdRp)	R1AB_CVEMC (RdRp)
			
DRUG0174	DRUGNAME	Ribavirin + lopinavir + ritonavir + interferon alfa-2a	
DRUG0174	DRUGTYPE	Combination drug	
DRUG0174	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0174	DRUGSTAT	Investigative Agent	
DRUG0174	TARGNAME	MERS-CoV RNA-directed RNA polymerase (RdRp)	R1AB_CVEMC (RdRp)
DRUG0174	TARGNAME	MERS-CoV 3C-like proteinase (3CLpro)	R1AB_CVEMC (3CLpro)
			
			
DRUG0175	DRUGNAME	Lopinavir + ritonavir + interferon beta	
DRUG0175	DRUGTYPE	Combination drug	
DRUG0175	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0175	DRUGSTAT	Investigative Agent	
DRUG0175	TARGNAME	MERS-CoV 3C-like proteinase (3CLpro)	R1AB_CVEMC (3CLpro)
			
DRUG0197	DRUGNAME	Triflupromazine	
DRUG0197	DRUGTYPE	Small molecular drug	
DRUG0197	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0197	DRUGSTAT	Investigative Agent	
DRUG0197	TARGNAME	HUMAN clathrin-mediated endocytosis (RME)	N.A.
DRUG0197	PCHEMCID	CID: 5568	
DRUG0197	HIGHSTAT	Withdrawn from market	
DRUG0197	HIGHDISE	Schizophrenia	
			
DRUG0200	DRUGNAME	Promethazine	
DRUG0200	DRUGTYPE	Small molecular drug	
DRUG0200	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0200	DRUGSTAT	Investigative Agent	
DRUG0200	TARGNAME	HUMAN clathrin-mediated endocytosis (RME)	N.A.
DRUG0200	PCHEMCID	CID: 4927	
			
DRUG0198	DRUGNAME	Fluphenazine	
DRUG0198	DRUGTYPE	Small molecular drug	
DRUG0198	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0198	DRUGSTAT	Investigative Agent	
DRUG0198	TARGNAME	HUMAN clathrin-mediated endocytosis (RME)	N.A.
DRUG0198	PCHEMCID	CID: 3372	
			
DRUG0199	DRUGNAME	Chlorpromazine	
DRUG0199	DRUGTYPE	Small molecular drug	
DRUG0199	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0199	DRUGSTAT	Investigative Agent	
DRUG0199	TARGNAME	HUMAN clathrin-mediated endocytosis (RME)	N.A.
DRUG0199	PCHEMCID	CID: 2726	
DRUG0199	HIGHSTAT	Withdrawn from market	
DRUG0199	HIGHDISE	Schizophrenia	
			
DRUG0201	DRUGNAME	Thiethylperazine	
DRUG0201	DRUGTYPE	Small molecular drug	
DRUG0201	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0201	DRUGSTAT	Investigative Agent	
DRUG0201	TARGNAME	HUMAN clathrin-mediated endocytosis (RME)	N.A.
DRUG0201	PCHEMCID	CID: 5440	
			
DRUG0303	DRUGNAME	K11777	
DRUG0303	DRUGTYPE	Small molecular drug	
DRUG0303	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0303	DRUGSTAT	Preclinical Drug	
DRUG0303	TARGNAME	HUMAN cathepsin L (CTSL)	CATL1_HUMAN
			
DRUG0301	DRUGNAME	E-64D	
DRUG0301	DRUGTYPE	Small molecular drug	
DRUG0301	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0301	DRUGSTAT	Preclinical Drug	
DRUG0301	TARGNAME	HUMAN cathepsin L (CTSL)	CATL1_HUMAN
DRUG0301	PCHEMCID	CID: 65663	
			
DRUG0187	DRUGNAME	FA-613	
DRUG0187	DRUGTYPE	Small molecular drug	
DRUG0187	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0187	DRUGSTAT	Preclinical Drug	
DRUG0187	TARGNAME	HUMAN dihydroorotate dehydrogenase (DHODH)	PYRD_HUMAN
			
DRUG0232	DRUGNAME	Galidesivir	
DRUG0232	DRUGTYPE	Small molecular drug	
DRUG0232	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0232	DRUGSTAT	Preclinical Drug	
DRUG0232	TARGNAME	SARS-CoV RNA-directed RNA polymerase (RdRp)	R1AB_CVHSA (RdRp)
DRUG0232	PCHEMCID	CID: 69211190	
			
DRUG0271	DRUGNAME	Thioguanine	
DRUG0271	DRUGTYPE	Small molecular drug	
DRUG0271	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0271	DRUGSTAT	Preclinical Drug	
DRUG0271	TARGNAME	SARS-CoV papain-like proteinase (PL-PRO)	R1AB_CVHSA (PL-PRO)
DRUG0271	PCHEMCID	CID: 2723601	
DRUG0271	HIGHSTAT	Approved	
DRUG0271	HIGHDISE	Acute lymphocytic leukaemia	
			
DRUG0272	DRUGNAME	Mercaptopurine	
DRUG0272	DRUGTYPE	Small molecular drug	
DRUG0272	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0272	DRUGSTAT	Preclinical Drug	
DRUG0272	TARGNAME	SARS-CoV papain-like proteinase (PL-PRO)	R1AB_CVHSA (PL-PRO)
DRUG0272	PCHEMCID	CID: 667490	
DRUG0272	HIGHSTAT	Approved	
DRUG0272	HIGHDISE	Acute lymphocytic leukaemia	
			
DRUG0302	DRUGNAME	PMID26868298-compound-5705213	
DRUG0302	DRUGTYPE	Small molecular drug	
DRUG0302	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0302	DRUGSTAT	Preclinical Drug	
DRUG0302	TARGNAME	HUMAN cathepsin L (CTSL)	CATL1_HUMAN
			
DRUG0290	DRUGNAME	PMID31244113-compound-2c	
DRUG0290	DRUGTYPE	Small molecular drug	
DRUG0290	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0290	DRUGSTAT	Preclinical Drug	
DRUG0290	TARGNAME	SARS-CoV RNA-directed RNA polymerase (RdRp)	R1AB_CVHSA (RdRp)
			
DRUG0296	DRUGNAME	PMID21925774-compound-5e	
DRUG0296	DRUGTYPE	Small molecular drug	
DRUG0296	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0296	DRUGSTAT	Preclinical Drug	
DRUG0296	TARGNAME	SARS-CoV helicase (Hel)	R1AB_CVHSA (Hel)
			
DRUG0283	DRUGNAME	SSYA10-001	
DRUG0283	DRUGTYPE	Small molecular drug	
DRUG0283	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0283	DRUGSTAT	Preclinical Drug	
DRUG0283	TARGNAME	SARS-CoV helicase (Hel)	R1AB_CVHSA (Hel)
			
DRUG0176	DRUGNAME	PMID26868298-compound-N3	
DRUG0176	DRUGTYPE	Small molecular drug	
DRUG0176	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0176	DRUGSTAT	Preclinical Drug	
DRUG0176	TARGNAME	SARS-CoV 3C-like protease (3CLpro)	R1AB_CVHSA (3CLpro)
			
DRUG0177	DRUGNAME	GRL-001	
DRUG0177	DRUGTYPE	Small molecular drug	
DRUG0177	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0177	DRUGSTAT	Preclinical Drug	
DRUG0177	TARGNAME	SARS-CoV 3C-like protease (3CLpro)	R1AB_CVHSA (3CLpro)
			
DRUG0178	DRUGNAME	Lopinavir	
DRUG0178	DRUGTYPE	Small molecular drug	
DRUG0178	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0178	DRUGSTAT	Preclinical Drug	
DRUG0178	TARGNAME	SARS-CoV 3C-like protease (3CLpro)	R1AB_CVHSA (3CLpro)
DRUG0178	PCHEMCID	CID: 92727	
DRUG0178	HIGHSTAT	Approved	
DRUG0178	HIGHDISE	Human immunodeficiency virus infection	
			
DRUG0179	DRUGNAME	GC376	
DRUG0179	DRUGTYPE	Small molecular drug	
DRUG0179	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0179	DRUGSTAT	Preclinical Drug	
DRUG0179	TARGNAME	SARS-CoV 3C-like protease (3CLpro)	R1AB_CVHSA (3CLpro)
DRUG0179	PCHEMCID	CID: 71481119	
			
DRUG0180	DRUGNAME	PMID27240464-compound-3f	
DRUG0180	DRUGTYPE	Small molecular drug	
DRUG0180	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0180	DRUGSTAT	Preclinical Drug	
DRUG0180	TARGNAME	SARS-CoV 3C-like protease (3CLpro)	R1AB_CVHSA (3CLpro)
			
DRUG0181	DRUGNAME	PMID28216367-compound-6d	
DRUG0181	DRUGTYPE	Small molecular drug	
DRUG0181	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0181	DRUGSTAT	Preclinical Drug	
DRUG0181	TARGNAME	SARS-CoV 3C-like protease (3CLpro)	R1AB_CVHSA (3CLpro)
			
DRUG0293	DRUGNAME	Phenylisoserine derivatives SK80	
DRUG0293	DRUGTYPE	Small molecular drug	
DRUG0293	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0293	DRUGSTAT	Preclinical Drug	
DRUG0293	TARGNAME	SARS-CoV 3C-like protease (3CLpro)	R1AB_CVHSA (3CLpro)
			
DRUG0294	DRUGNAME	PMID28624700-compound-3-31	
DRUG0294	DRUGTYPE	Small molecular drug	
DRUG0294	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0294	DRUGSTAT	Preclinical Drug	
DRUG0294	TARGNAME	SARS-CoV 3C-like protease (3CLpro)	R1AB_CVHSA (3CLpro)
			
DRUG0295	DRUGNAME	PMID30784880-compound-6-5	
DRUG0295	DRUGTYPE	Small molecular drug	
DRUG0295	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0295	DRUGSTAT	Preclinical Drug	
DRUG0295	TARGNAME	SARS-CoV 3C-like protease (3CLpro)	R1AB_CVHSA (3CLpro)
			
DRUG0269	DRUGNAME	Hexamethylene amiloride	
DRUG0269	DRUGTYPE	Small molecular drug	
DRUG0269	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0269	DRUGSTAT	Preclinical Drug	
DRUG0269	TARGNAME	SARS-CoV envelope small membrane protein (E)	VEMP_CVHSA
DRUG0269	PCHEMCID	CID: 1794	
			
DRUG0165	DRUGNAME	N-(2-aminoethyl)-1-aziridine-ethanamine	
DRUG0165	DRUGTYPE	Small molecular drug	
DRUG0165	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0165	DRUGSTAT	Investigative Agent	
DRUG0165	TARGNAME	HUMAN angiotensin-converting enzyme 2 (ACE2)	ACE2_HUMAN
			
DRUG0125	DRUGNAME	Imatinib	
DRUG0125	DRUGTYPE	Small molecular drug	
DRUG0125	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0125	DRUGSTAT	Investigative Agent	
DRUG0125	TARGNAME	HUMAN fusion protein Bcr-Abl (Bcr-Abl)	BCR_HUMAN-ABL1_HUMAN
DRUG0125	PCHEMCID	CID: 5291	
DRUG0125	HIGHSTAT	Approved	
DRUG0125	HIGHDISE	Chronic myeloid leukaemia	
			
DRUG0267	DRUGNAME	Dasatinib	
DRUG0267	DRUGTYPE	Small molecular drug	
DRUG0267	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0267	DRUGSTAT	Investigative Agent	
DRUG0267	TARGNAME	HUMAN fusion protein Bcr-Abl (Bcr-Abl)	BCR_HUMAN-ABL1_HUMAN
DRUG0267	PCHEMCID	CID: 3062316	
DRUG0267	HIGHSTAT	Approved	
DRUG0267	HIGHDISE	Chronic myeloid leukaemia	
			
DRUG0266	DRUGNAME	Trametinib	
DRUG0266	DRUGTYPE	Small molecular drug	
DRUG0266	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0266	DRUGSTAT	Investigative Agent	
DRUG0266	TARGNAME	HUMAN ERK activator kinase 1 (MEK1)	MP2K1_HUMAN
DRUG0266	TARGNAME	HUMAN ERK activator kinase 2 (MEK2)	MP2K2_HUMAN
DRUG0266	PCHEMCID	CID: 11707110	
DRUG0266	HIGHSTAT	Approved	
DRUG0266	HIGHDISE	Metastatic melanoma	
			
DRUG0265	DRUGNAME	Selumetinib	
DRUG0265	DRUGTYPE	Small molecular drug	
DRUG0265	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0265	DRUGSTAT	Investigative Agent	
DRUG0265	TARGNAME	HUMAN ERK activator kinase 1 (MEK1)	MP2K1_HUMAN
DRUG0265	TARGNAME	HUMAN ERK activator kinase 2 (MEK2)	MP2K2_HUMAN
DRUG0265	PCHEMCID	CID: 10127622	
DRUG0265	HIGHSTAT	Approved	
DRUG0265	HIGHDISE	Neurofibromatosis type 1	
			
DRUG0167	DRUGNAME	Rapamycin	
DRUG0167	DRUGTYPE	Small molecular drug	
DRUG0167	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0167	DRUGSTAT	Investigative Agent	
DRUG0167	TARGNAME	HUMAN mammalian target of rapamycin (mTOR)	MTOR_HUMAN
DRUG0167	PCHEMCID	CID: 6436030	
DRUG0167	HIGHSTAT	Approved	
DRUG0167	HIGHDISE	Lymphangioleiomyomatosis	
			
DRUG0168	DRUGNAME	Everolimus	
DRUG0168	DRUGTYPE	Small molecular drug	
DRUG0168	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0168	DRUGSTAT	Investigative Agent	
DRUG0168	TARGNAME	HUMAN mammalian target of rapamycin (mTOR)	MTOR_HUMAN
DRUG0168	PCHEMCID	CID: 6442177	
DRUG0168	HIGHSTAT	Approved	
DRUG0168	HIGHDISE	Advanced/metastatic breast cancer	
			
DRUG0152	DRUGNAME	Ribavirin	
DRUG0152	DRUGTYPE	Small molecular drug	
DRUG0152	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0152	DRUGSTAT	Investigative Agent	
DRUG0152	TARGNAME	SARS-CoV RNA-directed RNA polymerase (RdRp)	R1AB_CVHSA (RdRp)
DRUG0152	PCHEMCID	CID: 37542	
DRUG0152	HIGHSTAT	Approved	
DRUG0152	HIGHDISE	Hepatitis C virus infection	
			
DRUG0233	DRUGNAME	Remdesivir	
DRUG0233	DRUGTYPE	Small molecular drug	
DRUG0233	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0233	DRUGSTAT	Investigative Agent	
DRUG0233	TARGNAME	SARS-CoV RNA-directed RNA polymerase (RdRp)	R1AB_CVHSA (RdRp)
DRUG0233	PCHEMCID	CID: 121304016	
			
DRUG0291	DRUGNAME	PMID20527968-compound-6577871	
DRUG0291	DRUGTYPE	Small molecular drug	
DRUG0291	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0291	DRUGSTAT	Investigative Agent	
DRUG0291	TARGNAME	SARS-CoV papain-like proteinase (PL-PRO)	R1AB_CVHSA (PL-PRO)
			
DRUG0292	DRUGNAME	GRL-0667	
DRUG0292	DRUGTYPE	Small molecular drug	
DRUG0292	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0292	DRUGSTAT	Investigative Agent	
DRUG0292	TARGNAME	SARS-CoV papain-like proteinase (PL-PRO)	R1AB_CVHSA (PL-PRO)
DRUG0292	PCHEMCID	CID: 46174170	
			
DRUG0213	DRUGNAME	Disulfiram	
DRUG0213	DRUGTYPE	Small molecular drug	
DRUG0213	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0213	DRUGSTAT	Investigative Agent	
DRUG0213	TARGNAME	SARS-CoV papain-like proteinase (PL-PRO)	R1AB_CVHSA (PL-PRO)
DRUG0213	PCHEMCID	CID: 3117	
DRUG0213	HIGHSTAT	Approved	
DRUG0213	HIGHDISE	Alcohol dependence	
			
DRUG0171	DRUGNAME	Camostat mesylate	
DRUG0171	DRUGTYPE	Small molecular drug	
DRUG0171	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0171	DRUGSTAT	Investigative Agent	
DRUG0171	TARGNAME	HUMAN transmembrane protease serine 2 (TMPRSS2)	TMPS2_HUMAN
DRUG0171	PCHEMCID	CID: 5284360	
			
DRUG0305	DRUGNAME	Griffithsin	
DRUG0305	DRUGTYPE	Protein/peptide drug	
DRUG0305	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0305	DRUGSTAT	Preclinical Drug	
DRUG0305	TARGNAME	SARS-CoV spike glycoprotein (S)	SPIKE_CVHSA
DRUG0305	HIGHSTAT	Phase 1	
DRUG0305	HIGHDISE	Human immunodeficiency virus infection	
			
DRUG0276	DRUGNAME	PMID26911565-peptide-P9	
DRUG0276	DRUGTYPE	Protein/peptide drug	
DRUG0276	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0276	DRUGSTAT	Preclinical Drug	
DRUG0276	TARGNAME	SARS-CoV spike glycoprotein (S)	SPIKE_CVHSA
			
DRUG0264	DRUGNAME	Alisporivir	
DRUG0264	DRUGTYPE	Protein/peptide drug	
DRUG0264	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0264	DRUGSTAT	Investigative Agent	
DRUG0264	TARGNAME	HUMAN cyclophilin A (CYPA)	PPIA_HUMAN
DRUG0264	PCHEMCID	CID: 11513676	
DRUG0264	HIGHSTAT	Phase 3	
DRUG0264	HIGHDISE	Hepatitis C virus infection	
			
DRUG0263	DRUGNAME	Ciclosporin	
DRUG0263	DRUGTYPE	Protein/peptide drug	
DRUG0263	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0263	DRUGSTAT	Investigative Agent	
DRUG0263	TARGNAME	HUMAN cyclophilin D (CYP3)	PPIF_HUMAN
DRUG0263	PCHEMCID	CID: 24883466	
DRUG0263	HIGHSTAT	Approved	
DRUG0263	HIGHDISE	Graft-versus-host disease	
			
DRUG0250	DRUGNAME	Fusion peptide EK1	
DRUG0250	DRUGTYPE	Protein/peptide drug	
DRUG0250	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0250	DRUGSTAT	Investigative Agent	
DRUG0250	TARGNAME	SARS-CoV spike glycoprotein S2' HR1 region (S S2'HR1)	SPIKE_CVHSA (S2'HR1)
			
DRUG0197	DRUGNAME	Triflupromazine	
DRUG0197	DRUGTYPE	Small molecular drug	
DRUG0197	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0197	DRUGSTAT	Investigative Agent	
DRUG0197	TARGNAME	HUMAN clathrin-mediated endocytosis (RME)	N.A.
DRUG0197	PCHEMCID	CID: 5568	
DRUG0197	HIGHSTAT	Withdrawn from market	
DRUG0197	HIGHDISE	Schizophrenia	
			
DRUG0200	DRUGNAME	Promethazine	
DRUG0200	DRUGTYPE	Small molecular drug	
DRUG0200	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0200	DRUGSTAT	Investigative Agent	
DRUG0200	TARGNAME	HUMAN clathrin-mediated endocytosis (RME)	N.A.
DRUG0200	PCHEMCID	CID: 4927	
			
DRUG0198	DRUGNAME	Fluphenazine	
DRUG0198	DRUGTYPE	Small molecular drug	
DRUG0198	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0198	DRUGSTAT	Investigative Agent	
DRUG0198	TARGNAME	HUMAN clathrin-mediated endocytosis (RME)	N.A.
DRUG0198	PCHEMCID	CID: 3372	
			
DRUG0199	DRUGNAME	Chlorpromazine	
DRUG0199	DRUGTYPE	Small molecular drug	
DRUG0199	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0199	DRUGSTAT	Investigative Agent	
DRUG0199	TARGNAME	HUMAN clathrin-mediated endocytosis (RME)	N.A.
DRUG0199	PCHEMCID	CID: 2726	
DRUG0199	HIGHSTAT	Withdrawn from market	
DRUG0199	HIGHDISE	Schizophrenia	
			
DRUG0121	DRUGNAME	Oseltamivir	
DRUG0121	DRUGTYPE	Small molecular drug	
DRUG0121	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0121	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0121	PCHEMCID	CID: 65028	
DRUG0121	HIGHSTAT	Approved	
DRUG0121	HIGHDISE	Influenza virus infection	
			
DRUG0122	DRUGNAME	Tradipitant	
DRUG0122	DRUGTYPE	Small molecular drug	
DRUG0122	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0122	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0122	PCHEMCID	CID: 9916461	
			
DRUG0123	DRUGNAME	Azithromycin	
DRUG0123	DRUGTYPE	Small molecular drug	
DRUG0123	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0123	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0123	PCHEMCID	CID: 447043	
DRUG0123	HIGHSTAT	Approved	
DRUG0123	HIGHDISE	Bronchitis	
			
DRUG0124	DRUGNAME	Methylprednisolone	
DRUG0124	DRUGTYPE	Small molecular drug	
DRUG0124	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0124	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0124	PCHEMCID	CID: 6741	
DRUG0124	HIGHSTAT	Approved	
DRUG0124	HIGHDISE	Rheumatoid arthritis	
			
DRUG0125	DRUGNAME	Imatinib	
DRUG0125	DRUGTYPE	Small molecular drug	
DRUG0125	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0125	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0125	PCHEMCID	CID: 5291	
DRUG0125	HIGHSTAT	Approved	
DRUG0125	HIGHDISE	Chronic myeloid leukaemia	
			
DRUG0126	DRUGNAME	Ciclesonide	
DRUG0126	DRUGTYPE	Small molecular drug	
DRUG0126	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0126	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0126	PCHEMCID	CID: 6918155	
DRUG0126	HIGHSTAT	Approved	
DRUG0126	HIGHDISE	Asthma	
			
DRUG0127	DRUGNAME	Nitazoxanide	
DRUG0127	DRUGTYPE	Small molecular drug	
DRUG0127	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0127	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0127	PCHEMCID	CID: 41684	
DRUG0127	HIGHSTAT	Approved	
DRUG0127	HIGHDISE	Diarrhea	
			
DRUG0111	DRUGNAME	Ivermectin	
DRUG0111	DRUGTYPE	Small molecular drug	
DRUG0111	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0111	DRUGSTAT	Drug in Phase 2/3 Clinical Trial	
DRUG0111	PCHEMCID	CID: 6321424	
DRUG0111	HIGHSTAT	Approved	
DRUG0111	HIGHDISE	Onchocerciasis	
			
DRUG0112	DRUGNAME	Ifenprodil	
DRUG0112	DRUGTYPE	Small molecular drug	
DRUG0112	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0112	DRUGSTAT	Drug in Phase 2/3 Clinical Trial	
DRUG0112	PCHEMCID	CID: 3689	
			
DRUG0067	DRUGNAME	Arbidol	
DRUG0067	DRUGTYPE	Small molecular drug	
DRUG0067	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0067	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0067	PCHEMCID	CID: 131410	
DRUG0067	HIGHSTAT	Phase 4	
DRUG0067	HIGHDISE	Influenza virus infection	
			
DRUG0068	DRUGNAME	Thalidomide	
DRUG0068	DRUGTYPE	Small molecular drug	
DRUG0068	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0068	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0068	PCHEMCID	CID: 5426	
DRUG0068	HIGHSTAT	Approved	
DRUG0068	HIGHDISE	Multiple myeloma	
			
DRUG0069	DRUGNAME	N-acetylcysteine	
DRUG0069	DRUGTYPE	Small molecular drug	
DRUG0069	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0069	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0069	PCHEMCID	CID: 12035	
DRUG0069	HIGHSTAT	Approved	
DRUG0069	HIGHDISE	Cystic fibrosis	
			
DRUG0070	DRUGNAME	Fingolimod	
DRUG0070	DRUGTYPE	Small molecular drug	
DRUG0070	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0070	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0070	PCHEMCID	CID: 107970	
DRUG0070	HIGHSTAT	Approved	
DRUG0070	HIGHDISE	Multiple sclerosis	
			
DRUG0071	DRUGNAME	Carrimycin	
DRUG0071	DRUGTYPE	Small molecular drug	
DRUG0071	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0071	DRUGSTAT	Drug in Phase 2 Clinical Trial	
			
DRUG0072	DRUGNAME	Nitric Oxide	
DRUG0072	DRUGTYPE	Small molecular drug	
DRUG0072	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0072	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0072	PCHEMCID	CID: 145068	
DRUG0072	HIGHSTAT	Approved	
DRUG0072	HIGHDISE	Hypertension	
			
DRUG0073	DRUGNAME	Colchicine	
DRUG0073	DRUGTYPE	Small molecular drug	
DRUG0073	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0073	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0073	PCHEMCID	CID: 6167	
DRUG0073	HIGHSTAT	Approved	
DRUG0073	HIGHDISE	Gout	
			
DRUG0074	DRUGNAME	Tofacitinib	
DRUG0074	DRUGTYPE	Small molecular drug	
DRUG0074	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0074	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0074	PCHEMCID	CID: 9926791	
DRUG0074	HIGHSTAT	Approved	
DRUG0074	HIGHDISE	Rheumatoid arthritis	
			
DRUG0075	DRUGNAME	Piclidenoson	
DRUG0075	DRUGTYPE	Small molecular drug	
DRUG0075	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0075	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0075	PCHEMCID	CID: 123683	
DRUG0075	HIGHSTAT	Phase 3	
DRUG0075	HIGHDISE	Keratoconjunctivitis Sicca	
			
DRUG0076	DRUGNAME	Defibrotide	
DRUG0076	DRUGTYPE	Small molecular drug	
DRUG0076	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0076	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0076	PCHEMCID	CID: 135565962	
DRUG0076	HIGHSTAT	Approved	
DRUG0076	HIGHDISE	Hepatic Veno-Occlusive Disease	
			
DRUG0077	DRUGNAME	Nintedanib	
DRUG0077	DRUGTYPE	Small molecular drug	
DRUG0077	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0077	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0077	PCHEMCID	CID: 135423438	
DRUG0077	HIGHSTAT	Approved	
DRUG0077	HIGHDISE	Idiopathic pulmonary fibrosis	
			
DRUG0078	DRUGNAME	Fluvoxamine	
DRUG0078	DRUGTYPE	Small molecular drug	
DRUG0078	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0078	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0078	PCHEMCID	CID: 5324346	
DRUG0078	HIGHSTAT	Approved	
DRUG0078	HIGHDISE	Obsessive-compulsive disorder	
			
DRUG0079	DRUGNAME	CM4620	
DRUG0079	DRUGTYPE	Small molecular drug	
DRUG0079	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0079	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0079	PCHEMCID	CID: 122507647	
			
DRUG0013	DRUGNAME	Mefloquine	
DRUG0013	DRUGTYPE	Small molecular drug	
DRUG0013	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0013	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0013	PCHEMCID	CID: 40692	
DRUG0013	HIGHSTAT	Approved	
DRUG0013	HIGHDISE	Malaria	
			
DRUG0080	DRUGNAME	Clevudine	
DRUG0080	DRUGTYPE	Small molecular drug	
DRUG0080	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0080	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0080	PCHEMCID	CID: 73115	
DRUG0080	HIGHSTAT	Phase 4	
DRUG0080	HIGHDISE	Hepatitis B	
			
DRUG0081	DRUGNAME	Triiodothyronine	
DRUG0081	DRUGTYPE	Small molecular drug	
DRUG0081	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0081	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0081	PCHEMCID	CID: 5920	
DRUG0081	HIGHSTAT	Approved	
DRUG0081	HIGHDISE	Euthyroid goiter	
			
DRUG0082	DRUGNAME	Selinexor	
DRUG0082	DRUGTYPE	Small molecular drug	
DRUG0082	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0082	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0082	PCHEMCID	CID: 71481097	
DRUG0082	HIGHSTAT	Approved	
DRUG0082	HIGHDISE	Multiple myeloma	
			
DRUG0083	DRUGNAME	Etoposide	
DRUG0083	DRUGTYPE	Small molecular drug	
DRUG0083	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0083	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0083	PCHEMCID	CID: 36462	
DRUG0083	HIGHSTAT	Approved	
DRUG0083	HIGHDISE	Testicular neoplasms	
			
DRUG0084	DRUGNAME	AT-001	
DRUG0084	DRUGTYPE	Small molecular drug	
DRUG0084	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0084	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0084	PCHEMCID	CID: 56639723	
			
DRUG0085	DRUGNAME	Ketamine	
DRUG0085	DRUGTYPE	Small molecular drug	
DRUG0085	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0085	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0085	PCHEMCID	CID: 3821	
DRUG0085	HIGHSTAT	Approved	
DRUG0085	HIGHDISE	Anaesthesia	
			
DRUG0086	DRUGNAME	Naltrexone	
DRUG0086	DRUGTYPE	Small molecular drug	
DRUG0086	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0086	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0086	PCHEMCID	CID: 5360515	
DRUG0086	HIGHSTAT	Approved	
DRUG0086	HIGHDISE	Alcoholism	
			
DRUG0087	DRUGNAME	Melphalan	
DRUG0087	DRUGTYPE	Small molecular drug	
DRUG0087	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0087	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0087	PCHEMCID	CID: 460612	
DRUG0087	HIGHSTAT	Approved	
DRUG0087	HIGHDISE	Ovarian neoplasms	
			
DRUG0088	DRUGNAME	ArtemiC	
DRUG0088	DRUGTYPE	Small molecular drug	
DRUG0088	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0088	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0088	PCHEMCID	CID: 11629819	
			
DRUG0306	DRUGNAME	VERU-111	
DRUG0306	DRUGTYPE	Small molecular drug	
DRUG0306	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0306	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0306	PCHEMCID	CID: 53379371	
			
DRUG0057	DRUGNAME	Deferoxamine	
DRUG0057	DRUGTYPE	Small molecular drug	
DRUG0057	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0057	DRUGSTAT	Drug in Phase 1/2 Clinical Trial	
DRUG0057	PCHEMCID	CID: 2973	
DRUG0057	HIGHSTAT	Approved	
DRUG0057	HIGHDISE	Acute iron or aluminum toxicity	
			
DRUG0058	DRUGNAME	Indomethacin	
DRUG0058	DRUGTYPE	Small molecular drug	
DRUG0058	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0058	DRUGSTAT	Drug in Phase 1/2 Clinical Trial	
DRUG0058	PCHEMCID	CID: 3715	
DRUG0058	HIGHSTAT	Approved	
DRUG0058	HIGHDISE	Rheumatoid arthritis	
			
DRUG0059	DRUGNAME	Methotrexate	
DRUG0059	DRUGTYPE	Small molecular drug	
DRUG0059	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0059	DRUGSTAT	Drug in Phase 1/2 Clinical Trial	
DRUG0059	PCHEMCID	CID: 126941	
DRUG0059	HIGHSTAT	Approved	
DRUG0059	HIGHDISE	Choriocarcinoma	
			
DRUG0060	DRUGNAME	AVM0703	
DRUG0060	DRUGTYPE	Small molecular drug	
DRUG0060	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0060	DRUGSTAT	Drug in Phase 1/2 Clinical Trial	
			
DRUG0044	DRUGNAME	TAK-981	
DRUG0044	DRUGTYPE	Small molecular drug	
DRUG0044	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0044	DRUGSTAT	Drug in Phase 1 Clinical Trial	
DRUG0044	PCHEMCID	CID: 118628567	
			
DRUG0045	DRUGNAME	Progesterone	
DRUG0045	DRUGTYPE	Small molecular drug	
DRUG0045	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0045	DRUGSTAT	Drug in Phase 1 Clinical Trial	
DRUG0045	PCHEMCID	CID: 5994	
DRUG0045	HIGHSTAT	Approved	
DRUG0045	HIGHDISE	Amenorrhea	
			
DRUG0046	DRUGNAME	Sulfonatoporphyrin	
DRUG0046	DRUGTYPE	Small molecular drug	
DRUG0046	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0046	DRUGSTAT	Drug in Phase 1 Clinical Trial	
DRUG0046	PCHEMCID	CID: 129653953	
			
DRUG0047	DRUGNAME	SnPP Protoporphyrin	
DRUG0047	DRUGTYPE	Small molecular drug	
DRUG0047	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0047	DRUGSTAT	Drug in Phase 1 Clinical Trial	
DRUG0047	PCHEMCID	CID: 73755113	
			
DRUG0048	DRUGNAME	Plitidepsin	
DRUG0048	DRUGTYPE	Small molecular drug	
DRUG0048	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0048	DRUGSTAT	Drug in Phase 1 Clinical Trial	
DRUG0048	PCHEMCID	CID: 9812534	
			
DRUG0139	DRUGNAME	TMCB	
DRUG0139	DRUGTYPE	Small molecular drug	
DRUG0139	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0139	DRUGSTAT	Investigative Agent	
DRUG0139	PCHEMCID	CID: 46943415	
			
DRUG0140	DRUGNAME	Indinavir	
DRUG0140	DRUGTYPE	Small molecular drug	
DRUG0140	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0140	DRUGSTAT	Investigative Agent	
DRUG0140	PCHEMCID	CID: 5362440	
DRUG0140	HIGHSTAT	Approved	
DRUG0140	HIGHDISE	HIV infections	
			
DRUG0141	DRUGNAME	Amprenavir	
DRUG0141	DRUGTYPE	Small molecular drug	
DRUG0141	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0141	DRUGSTAT	Investigative Agent	
DRUG0141	PCHEMCID	CID: 65016	
DRUG0141	HIGHSTAT	Approved	
DRUG0141	HIGHDISE	HIV infections	
			
DRUG0142	DRUGNAME	Triazavirin	
DRUG0142	DRUGTYPE	Small molecular drug	
DRUG0142	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0142	DRUGSTAT	Investigative Agent	
DRUG0142	PCHEMCID	CID: 3113817	
DRUG0142	HIGHSTAT	Phase 2	
DRUG0142	HIGHDISE	Influenza virus infection	
			
DRUG0143	DRUGNAME	Linezolid	
DRUG0143	DRUGTYPE	Small molecular drug	
DRUG0143	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0143	DRUGSTAT	Investigative Agent	
DRUG0143	PCHEMCID	CID: 441401	
DRUG0143	HIGHSTAT	Approved	
DRUG0143	HIGHDISE	Bacterial infections	
			
DRUG0144	DRUGNAME	Oxymethalone	
DRUG0144	DRUGTYPE	Small molecular drug	
DRUG0144	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0144	DRUGSTAT	Investigative Agent	
DRUG0144	PCHEMCID	CID: 5281034	
			
DRUG0145	DRUGNAME	Heparin	
DRUG0145	DRUGTYPE	Small molecular drug	
DRUG0145	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0145	DRUGSTAT	Investigative Agent	
DRUG0145	PCHEMCID	CID: 772	
DRUG0145	HIGHSTAT	Approved	
DRUG0145	HIGHDISE	Venous thrombosis	
			
DRUG0146	DRUGNAME	EIDD-2801	
DRUG0146	DRUGTYPE	Small molecular drug	
DRUG0146	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0146	DRUGSTAT	Investigative Agent	
DRUG0146	PCHEMCID	CID: 145996610	
			
DRUG0147	DRUGNAME	EIDD-1931	
DRUG0147	DRUGTYPE	Small molecular drug	
DRUG0147	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0147	DRUGSTAT	Investigative Agent	
DRUG0147	PCHEMCID	CID: 353014	
			
DRUG0128	DRUGNAME	DAS181	
DRUG0128	DRUGTYPE	Protein/peptide drug	
DRUG0128	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0128	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0128	PCHEMCID	SID: 381125922	
			
DRUG0129	DRUGNAME	Interferon beta-1a	
DRUG0129	DRUGTYPE	Protein/peptide drug	
DRUG0129	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0129	DRUGSTAT	Drug in Phase 3 Clinical Trial	
DRUG0129	HIGHSTAT	Approved	
DRUG0129	HIGHDISE	Multiple sclerosis	
			
DRUG0113	DRUGNAME	Aviptadil	
DRUG0113	DRUGTYPE	Protein/peptide drug	
DRUG0113	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0113	DRUGSTAT	Drug in Phase 2/3 Clinical Trial	
DRUG0113	PCHEMCID	CID: 16132300	
			
DRUG0114	DRUGNAME	Angiotensin (1-7)	
DRUG0114	DRUGTYPE	Protein/peptide drug	
DRUG0114	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0114	DRUGSTAT	Drug in Phase 2/3 Clinical Trial	
DRUG0114	PCHEMCID	CID: 123805	
			
DRUG0089	DRUGNAME	Thymosin	
DRUG0089	DRUGTYPE	Protein/peptide drug	
DRUG0089	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0089	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0089	PCHEMCID	CID: 44286042	
			
DRUG0090	DRUGNAME	Pegylated interferon lambda	
DRUG0090	DRUGTYPE	Protein/peptide drug	
DRUG0090	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0090	DRUGSTAT	Drug in Phase 2 Clinical Trial	
			
DRUG0091	DRUGNAME	Peginterferon lambda alfa-1a	
DRUG0091	DRUGTYPE	Protein/peptide drug	
DRUG0091	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0091	DRUGSTAT	Drug in Phase 2 Clinical Trial	
			
DRUG0092	DRUGNAME	Peginterferon lambda-1a	
DRUG0092	DRUGTYPE	Protein/peptide drug	
DRUG0092	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0092	DRUGSTAT	Drug in Phase 2 Clinical Trial	
			
DRUG0093	DRUGNAME	Dornase alfa	
DRUG0093	DRUGTYPE	Protein/peptide drug	
DRUG0093	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0093	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0093	HIGHSTAT	Approved	
DRUG0093	HIGHDISE	Cystic fibrosis	
			
DRUG0094	DRUGNAME	DFV890	
DRUG0094	DRUGTYPE	Protein/peptide drug	
DRUG0094	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0094	DRUGSTAT	Drug in Phase 2 Clinical Trial	
			
DRUG0037	DRUGNAME	Interferon-alpha 2b	
DRUG0037	DRUGTYPE	Protein/peptide drug	
DRUG0037	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0037	DRUGSTAT	Drug in Early Phase 1 Clinical Trial	
DRUG0037	HIGHSTAT	Approved	
DRUG0037	HIGHDISE	Hairy cell leukemia	
			
DRUG0148	DRUGNAME	BXT-25	
DRUG0148	DRUGTYPE	Protein/peptide drug	
DRUG0148	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0148	DRUGSTAT	Investigative Agent	
			
DRUG0130	DRUGNAME	Ritonavir + oseltamivir	
DRUG0130	DRUGTYPE	Combination drug	
DRUG0130	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0130	DRUGSTAT	Drug in Phase 3 Clinical Trial	
			
DRUG0131	DRUGNAME	Hydroxychloroquine + camostat mesylate	
DRUG0131	DRUGTYPE	Combination drug	
DRUG0131	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0131	DRUGSTAT	Drug in Phase 3 Clinical Trial	
			
DRUG0132	DRUGNAME	Hydroxychloroquine + intravenous famotidine	
DRUG0132	DRUGTYPE	Combination drug	
DRUG0132	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0132	DRUGSTAT	Drug in Phase 3 Clinical Trial	
			
DRUG0133	DRUGNAME	Hydroxychloroquine + azithromycin	
DRUG0133	DRUGTYPE	Combination drug	
DRUG0133	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0133	DRUGSTAT	Drug in Phase 3 Clinical Trial	
			
DRUG0134	DRUGNAME	Diltiazem + niclosamide	
DRUG0134	DRUGTYPE	Combination drug	
DRUG0134	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0134	DRUGSTAT	Drug in Phase 3 Clinical Trial	
			
DRUG0135	DRUGNAME	Nitazoxanide + ivermectin + chloroquine	
DRUG0135	DRUGTYPE	Combination drug	
DRUG0135	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0135	DRUGSTAT	Drug in Phase 3 Clinical Trial	
			
DRUG0136	DRUGNAME	Levamisole + isoprinosine	
DRUG0136	DRUGTYPE	Combination drug	
DRUG0136	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0136	DRUGSTAT	Drug in Phase 3 Clinical Trial	
			
DRUG0115	DRUGNAME	Levamisole Pill + Budesonide+Formoterol inhaler	
DRUG0115	DRUGTYPE	Combination drug	
DRUG0115	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0115	DRUGSTAT	Drug in Phase 2/3 Clinical Trial	
			
DRUG0116	DRUGNAME	Lopinavir + ritonavir + hydoxychloroquine	
DRUG0116	DRUGTYPE	Combination drug	
DRUG0116	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0116	DRUGSTAT	Drug in Phase 2/3 Clinical Trial	
			
DRUG0117	DRUGNAME	Ivermectin + nitazoxanide	
DRUG0117	DRUGTYPE	Combination drug	
DRUG0117	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0117	DRUGSTAT	Drug in Phase 2/3 Clinical Trial	
			
DRUG0118	DRUGNAME	Hydroxychloroquine + nitazoxanide	
DRUG0118	DRUGTYPE	Combination drug	
DRUG0118	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0118	DRUGSTAT	Drug in Phase 2/3 Clinical Trial	
			
DRUG0119	DRUGNAME	Metenkefalin + tridecactide	
DRUG0119	DRUGTYPE	Combination drug	
DRUG0119	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0119	DRUGSTAT	Drug in Phase 2/3 Clinical Trial	
			
DRUG0120	DRUGNAME	RPH-104 + Olokizumab	
DRUG0120	DRUGTYPE	Combination drug	
DRUG0120	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0120	DRUGSTAT	Drug in Phase 2/3 Clinical Trial	
			
DRUG0095	DRUGNAME	Thalidomide + hormones	
DRUG0095	DRUGTYPE	Combination drug	
DRUG0095	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0095	DRUGSTAT	Drug in Phase 2 Clinical Trial	
			
DRUG0096	DRUGNAME	Ribavirin + lopinavir + ritonavir + interferon beta-1b	
DRUG0096	DRUGTYPE	Combination drug	
DRUG0096	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0096	DRUGSTAT	Drug in Phase 2 Clinical Trial	
			
DRUG0097	DRUGNAME	N-acetylcysteine + Fuzheng Huayu	
DRUG0097	DRUGTYPE	Combination drug	
DRUG0097	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0097	DRUGSTAT	Drug in Phase 2 Clinical Trial	
			
DRUG0098	DRUGNAME	Danoprevir + ritonavir + interferon	
DRUG0098	DRUGTYPE	Combination drug	
DRUG0098	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0098	DRUGSTAT	Drug in Phase 2 Clinical Trial	
			
DRUG0099	DRUGNAME	Danoprevir + ritonavir	
DRUG0099	DRUGTYPE	Combination drug	
DRUG0099	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0099	DRUGSTAT	Drug in Phase 2 Clinical Trial	
			
DRUG0100	DRUGNAME	Atovaquone + azithromycin	
DRUG0100	DRUGTYPE	Combination drug	
DRUG0100	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0100	DRUGSTAT	Drug in Phase 2 Clinical Trial	
			
DRUG0101	DRUGNAME	Hydroxychloroquine + azithromycin + tocilizumab	
DRUG0101	DRUGTYPE	Combination drug	
DRUG0101	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0101	DRUGSTAT	Drug in Phase 2 Clinical Trial	
			
DRUG0102	DRUGNAME	Mefloquine + azithromycin	
DRUG0102	DRUGTYPE	Combination drug	
DRUG0102	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0102	DRUGSTAT	Drug in Phase 2 Clinical Trial	
			
DRUG0103	DRUGNAME	Mefloquine + azithromycin +  tocilizumab	
DRUG0103	DRUGTYPE	Combination drug	
DRUG0103	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0103	DRUGSTAT	Drug in Phase 2 Clinical Trial	
			
DRUG0104	DRUGNAME	Ruxolitinib + simvastatin	
DRUG0104	DRUGTYPE	Combination drug	
DRUG0104	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0104	DRUGSTAT	Drug in Phase 2 Clinical Trial	
			
DRUG0105	DRUGNAME	Hydroxychloroquine + ivermectin	
DRUG0105	DRUGTYPE	Combination drug	
DRUG0105	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0105	DRUGSTAT	Drug in Phase 2 Clinical Trial	
			
DRUG0049	DRUGNAME	Hydroxychloroquin + azithromycin + ivermectin	
DRUG0049	DRUGTYPE	Combination drug	
DRUG0049	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0049	DRUGSTAT	Drug in Phase 1 Clinical Trial	
			
DRUG0050	DRUGNAME	MCN (Methylene blue, vitamin C, N-acetyl cysteine)	
DRUG0050	DRUGTYPE	Combination drug	
DRUG0050	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0050	DRUGSTAT	Drug in Phase 1 Clinical Trial	
			
DRUG0106	DRUGNAME	Umbilical Cord Mesenchymal Stem Cells	
DRUG0106	DRUGTYPE	Cell therapy	
DRUG0106	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0106	DRUGSTAT	Drug in Phase 2 Clinical Trial	
			
DRUG0107	DRUGNAME	Mesenchymal stem cells	
DRUG0107	DRUGTYPE	Cell therapy	
DRUG0107	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0107	DRUGSTAT	Drug in Phase 2 Clinical Trial	
DRUG0107	HIGHSTAT	Approved	
DRUG0107	HIGHDISE	Epidermolysis Bullosa	
			
DRUG0108	DRUGNAME	HB-adMSCs cell	
DRUG0108	DRUGTYPE	Cell therapy	
DRUG0108	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0108	DRUGSTAT	Drug in Phase 2 Clinical Trial	
			
DRUG0109	DRUGNAME	Mesenchymal stromal cells	
DRUG0109	DRUGTYPE	Cell therapy	
DRUG0109	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0109	DRUGSTAT	Drug in Phase 2 Clinical Trial	
			
DRUG0110	DRUGNAME	Dialyzable leukocyte cell	
DRUG0110	DRUGTYPE	Cell therapy	
DRUG0110	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0110	DRUGSTAT	Drug in Phase 2 Clinical Trial	
			
DRUG0066	DRUGNAME	Ad5-nCoV	
DRUG0066	DRUGTYPE	Vaccine	
DRUG0066	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0066	DRUGSTAT	Drug in Phase 2 Clinical Trial	
			
DRUG0061	DRUGNAME	Natural killer cells	
DRUG0061	DRUGTYPE	Cell therapy	
DRUG0061	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0061	DRUGSTAT	Drug in Phase 1/2 Clinical Trial	
			
DRUG0062	DRUGNAME	Allogeneic human dental pulp stem cells (BSH BTC & Utooth BTC)	
DRUG0062	DRUGTYPE	Cell therapy	
DRUG0062	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0062	DRUGSTAT	Drug in Phase 1/2 Clinical Trial	
			
DRUG0063	DRUGNAME	Allogeneic NK transfer	
DRUG0063	DRUGTYPE	Cell therapy	
DRUG0063	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0063	DRUGSTAT	Drug in Phase 1/2 Clinical Trial	
			
DRUG0064	DRUGNAME	BM-MSCs cell	
DRUG0064	DRUGTYPE	Cell therapy	
DRUG0064	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0064	DRUGSTAT	Drug in Phase 1/2 Clinical Trial	
			
DRUG0065	DRUGNAME	CYNK-001	
DRUG0065	DRUGTYPE	Cell therapy	
DRUG0065	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0065	DRUGSTAT	Drug in Phase 1/2 Clinical Trial	
			
DRUG0054	DRUGNAME	LV-SMENP-DC	
DRUG0054	DRUGTYPE	Vaccine	
DRUG0054	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0054	DRUGSTAT	Drug in Phase 1/2 Clinical Trial	
			
DRUG0055	DRUGNAME	ChAdOx1 nCoV-19	
DRUG0055	DRUGTYPE	Vaccine	
DRUG0055	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0055	DRUGSTAT	Drug in Phase 1/2 Clinical Trial	
			
DRUG0056	DRUGNAME	BNT162a1	
DRUG0056	DRUGTYPE	Vaccine	
DRUG0056	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0056	DRUGSTAT	Drug in Phase 1/2 Clinical Trial	
			
DRUG0051	DRUGNAME	Wharton's Jelly-Mesenchymal Stem Cells	
DRUG0051	DRUGTYPE	Cell therapy	
DRUG0051	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0051	DRUGSTAT	Drug in Phase 1 Clinical Trial	
			
DRUG0052	DRUGNAME	Nest mesenchymal stem cells	
DRUG0052	DRUGTYPE	Cell therapy	
DRUG0052	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0052	DRUGSTAT	Drug in Phase 1 Clinical Trial	
			
DRUG0053	DRUGNAME	FT516	
DRUG0053	DRUGTYPE	Cell therapy	
DRUG0053	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0053	DRUGSTAT	Drug in Phase 1 Clinical Trial	
			
DRUG0038	DRUGNAME	mRNA-1273	
DRUG0038	DRUGTYPE	Vaccine	
DRUG0038	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0038	DRUGSTAT	Drug in Phase 1 Clinical Trial	
			
DRUG0039	DRUGNAME	Pathogen-specific aAPC	
DRUG0039	DRUGTYPE	Vaccine	
DRUG0039	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0039	DRUGSTAT	Drug in Phase 1 Clinical Trial	
			
DRUG0040	DRUGNAME	Covid-19 aAPC	
DRUG0040	DRUGTYPE	Vaccine	
DRUG0040	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0040	DRUGSTAT	Drug in Phase 1 Clinical Trial	
			
DRUG0041	DRUGNAME	BacTRL-Spike	
DRUG0041	DRUGTYPE	Vaccine	
DRUG0041	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0041	DRUGSTAT	Drug in Phase 1 Clinical Trial	
			
DRUG0042	DRUGNAME	INO-4800	
DRUG0042	DRUGTYPE	Vaccine	
DRUG0042	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0042	DRUGSTAT	Drug in Phase 1 Clinical Trial	
			
DRUG0043	DRUGNAME	SARS-CoV-2 rS vaccine	
DRUG0043	DRUGTYPE	Vaccine	
DRUG0043	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0043	DRUGSTAT	Drug in Phase 1 Clinical Trial	
			
DRUG0149	DRUGNAME	TNX-1800 vaccine	
DRUG0149	DRUGTYPE	Vaccine	
DRUG0149	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0149	DRUGSTAT	Preclinical Drug	
			
DRUG0150	DRUGNAME	Li-Key peptide vaccine	
DRUG0150	DRUGTYPE	Vaccine	
DRUG0150	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0150	DRUGSTAT	Preclinical Drug	
			
DRUG0137	DRUGNAME	Linear DNA vaccine	
DRUG0137	DRUGTYPE	Vaccine	
DRUG0137	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0137	DRUGSTAT	Investigative Agent	
			
DRUG0138	DRUGNAME	NasoVAX vaccine	
DRUG0138	DRUGTYPE	Vaccine	
DRUG0138	DISEASES	Coronavirus Disease 2019 (COVID-19)	
DRUG0138	DRUGSTAT	Investigative Agent	
			
			
DRUG0011	DRUGNAME	Loperamide	
DRUG0011	DRUGTYPE	Small molecular drug	
DRUG0011	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0011	DRUGSTAT	Preclinical Drug	
DRUG0011	PCHEMCID	CID: 3955	
DRUG0011	HIGHSTAT	Approved	
DRUG0011	HIGHDISE	Diarrhea	
			
DRUG0012	DRUGNAME	Amodiaquine	
DRUG0012	DRUGTYPE	Small molecular drug	
DRUG0012	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0012	DRUGSTAT	Preclinical Drug	
DRUG0012	PCHEMCID	CID: 2165	
DRUG0012	HIGHSTAT	Withdrawn from market	
DRUG0012	HIGHDISE	Malaria	
			
DRUG0013	DRUGNAME	Mefloquine	
DRUG0013	DRUGTYPE	Small molecular drug	
DRUG0013	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0013	DRUGSTAT	Preclinical Drug	
DRUG0013	PCHEMCID	CID: 40692	
DRUG0013	HIGHSTAT	Approved	
DRUG0013	HIGHDISE	Malaria	
			
DRUG0014	DRUGNAME	Gemcitabine	
DRUG0014	DRUGTYPE	Small molecular drug	
DRUG0014	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0014	DRUGSTAT	Preclinical Drug	
DRUG0014	PCHEMCID	CID: 60750	
DRUG0014	HIGHSTAT	Approved	
DRUG0014	HIGHDISE	Non-small cell lung cancer	
			
DRUG0015	DRUGNAME	K22	
DRUG0015	DRUGTYPE	Small molecular drug	
DRUG0015	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0015	DRUGSTAT	Preclinical Drug	
			
DRUG0036	DRUGNAME	Resveratrol	
DRUG0036	DRUGTYPE	Small molecular drug	
DRUG0036	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0036	DRUGSTAT	Preclinical Drug	
DRUG0036	PCHEMCID	CID: 445154	
			
DRUG0010	DRUGNAME	Chloroquine	
DRUG0010	DRUGTYPE	Small molecular drug	
DRUG0010	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0010	DRUGSTAT	Investigative Agent	
DRUG0010	PCHEMCID	CID: 2719	
DRUG0010	HIGHSTAT	Withdrawn from market	
DRUG0010	HIGHDISE	Malaria	
			
DRUG0030	DRUGNAME	Saracatinib	
DRUG0030	DRUGTYPE	Small molecular drug	
DRUG0030	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0030	DRUGSTAT	Investigative Agent	
DRUG0030	PCHEMCID	CID: 10302451	
DRUG0030	HIGHSTAT	Phase 2	
DRUG0030	HIGHDISE	Metastatic colorectal cancer	
			
DRUG0031	DRUGNAME	Emetine hydrochloride	
DRUG0031	DRUGTYPE	Small molecular drug	
DRUG0031	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0031	DRUGSTAT	Investigative Agent	
DRUG0031	PCHEMCID	CID: 10219	
			
DRUG0032	DRUGNAME	Monensin sodium	
DRUG0032	DRUGTYPE	Small molecular drug	
DRUG0032	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0032	DRUGSTAT	Investigative Agent	
DRUG0032	PCHEMCID	CID: 23667299	
			
DRUG0033	DRUGNAME	Phenazopyridine	
DRUG0033	DRUGTYPE	Small molecular drug	
DRUG0033	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0033	DRUGSTAT	Investigative Agent	
DRUG0033	PCHEMCID	CID: 4756	
			
DRUG0034	DRUGNAME	Mycophenolate mofetil	
DRUG0034	DRUGTYPE	Small molecular drug	
DRUG0034	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0034	DRUGSTAT	Investigative Agent	
DRUG0034	PCHEMCID	CID: 5281078	
			
DRUG0035	DRUGNAME	Pyrvinium pamoate	
DRUG0035	DRUGTYPE	Small molecular drug	
DRUG0035	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0035	DRUGSTAT	Investigative Agent	
DRUG0035	PCHEMCID	CID: 54680693	
			
DRUG0017	DRUGNAME	SAB-301	
DRUG0017	DRUGTYPE	Polyclonal antibody	
DRUG0017	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0017	DRUGSTAT	Discontinue Drug in Phase 1 Clinical Trial	
			
DRUG0018	DRUGNAME	REGN3048 + REGN3051 mabs	
DRUG0018	DRUGTYPE	Combination drug	
DRUG0018	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0018	DRUGSTAT	Discontinue Drug in Phase 1 Clinical Trial	
			
DRUG0024	DRUGNAME	MVA-MERS-S_DF-1 vaccine	
DRUG0024	DRUGTYPE	Vaccine	
DRUG0024	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0024	DRUGSTAT	Drug in Phase 1b Clinical Trial	
			
DRUG0021	DRUGNAME	GLS-5300	
DRUG0021	DRUGTYPE	Vaccine	
DRUG0021	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0021	DRUGSTAT	Drug in Phase 1/2 Clinical Trial	
			
DRUG0022	DRUGNAME	BVRS-GamVac-Combi	
DRUG0022	DRUGTYPE	Vaccine	
DRUG0022	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0022	DRUGSTAT	Drug in Phase 1/2 Clinical Trial	
			
DRUG0023	DRUGNAME	BVRS-GamVac	
DRUG0023	DRUGTYPE	Vaccine	
DRUG0023	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0023	DRUGSTAT	Drug in Phase 1/2 Clinical Trial	
			
DRUG0019	DRUGNAME	ChAdOx1 MERS001	
DRUG0019	DRUGTYPE	Vaccine	
DRUG0019	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0019	DRUGSTAT	Drug in Phase 1 Clinical Trial	
			
DRUG0020	DRUGNAME	ChAdOx1 MERS002	
DRUG0020	DRUGTYPE	Vaccine	
DRUG0020	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0020	DRUGSTAT	Drug in Phase 1 Clinical Trial	
			
DRUG0025	DRUGNAME	MERS-CoV SDNA	
DRUG0025	DRUGTYPE	Vaccine	
DRUG0025	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0025	DRUGSTAT	Investigative Agent	
			
DRUG0026	DRUGNAME	rMERS-CoV E	
DRUG0026	DRUGTYPE	Vaccine	
DRUG0026	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0026	DRUGSTAT	Investigative Agent	
			
DRUG0027	DRUGNAME	VRP S	
DRUG0027	DRUGTYPE	Vaccine	
DRUG0027	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0027	DRUGSTAT	Investigative Agent	
			
DRUG0028	DRUGNAME	S(377-588)-Fc	
DRUG0028	DRUGTYPE	Vaccine	
DRUG0028	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0028	DRUGSTAT	Investigative Agent	
			
DRUG0029	DRUGNAME	MERS-CoVS-containing nanoparticles	
DRUG0029	DRUGTYPE	Vaccine	
DRUG0029	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0029	DRUGSTAT	Investigative Agent	
			
DRUG0016	DRUGNAME	MVA-MERS-S vaccine	
DRUG0016	DRUGTYPE	Vaccine	
DRUG0016	DISEASES	Middle East Respiratory Syndrome (MERS)	
DRUG0016	DRUGSTAT	Discontinue Drug in Phase 1 Clinical Trial	
			
			
DRUG0011	DRUGNAME	Loperamide	
DRUG0011	DRUGTYPE	Small molecular drug	
DRUG0011	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0011	DRUGSTAT	Preclinical Drug	
DRUG0011	PCHEMCID	CID: 3955	
DRUG0011	HIGHSTAT	Approved	
DRUG0011	HIGHDISE	Diarrhea	
			
DRUG0012	DRUGNAME	Amodiaquine	
DRUG0012	DRUGTYPE	Small molecular drug	
DRUG0012	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0012	DRUGSTAT	Preclinical Drug	
DRUG0012	PCHEMCID	CID: 2165	
DRUG0012	HIGHSTAT	Withdrawn from market	
DRUG0012	HIGHDISE	Malaria	
			
DRUG0013	DRUGNAME	Mefloquine	
DRUG0013	DRUGTYPE	Small molecular drug	
DRUG0013	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0013	DRUGSTAT	Preclinical Drug	
DRUG0013	PCHEMCID	CID: 40692	
DRUG0013	HIGHSTAT	Approved	
DRUG0013	HIGHDISE	Malaria	
			
DRUG0014	DRUGNAME	Gemcitabine	
DRUG0014	DRUGTYPE	Small molecular drug	
DRUG0014	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0014	DRUGSTAT	Preclinical Drug	
DRUG0014	PCHEMCID	CID: 60750	
DRUG0014	HIGHSTAT	Approved	
DRUG0014	HIGHDISE	Non-small cell lung cancer	
			
DRUG0015	DRUGNAME	K22	
DRUG0015	DRUGTYPE	Small molecular drug	
DRUG0015	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0015	DRUGSTAT	Preclinical Drug	
			
DRUG0006	DRUGNAME	Zanamivir	
DRUG0006	DRUGTYPE	Small molecular drug	
DRUG0006	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0006	DRUGSTAT	Investigative Agent	
DRUG0006	PCHEMCID	CID: 60855	
DRUG0006	HIGHSTAT	Approved	
DRUG0006	HIGHDISE	Influenza	
			
DRUG0007	DRUGNAME	Rimantadine	
DRUG0007	DRUGTYPE	Small molecular drug	
DRUG0007	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0007	DRUGSTAT	Investigative Agent	
DRUG0007	PCHEMCID	CID: 5071	
DRUG0007	HIGHSTAT	Approved	
DRUG0007	HIGHDISE	Influenza	
			
DRUG0008	DRUGNAME	4E2Rcat	
DRUG0008	DRUGTYPE	Small molecular drug	
DRUG0008	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0008	DRUGSTAT	Investigative Agent	
DRUG0008	PCHEMCID	CID: 2287236	
			
DRUG0009	DRUGNAME	Amantadine	
DRUG0009	DRUGTYPE	Small molecular drug	
DRUG0009	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0009	DRUGSTAT	Investigative Agent	
DRUG0009	PCHEMCID	CID: 2130	
DRUG0009	HIGHSTAT	Approved	
DRUG0009	HIGHDISE	Influenza	
			
DRUG0010	DRUGNAME	Chloroquine	
DRUG0010	DRUGTYPE	Small molecular drug	
DRUG0010	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0010	DRUGSTAT	Investigative Agent	
DRUG0010	PCHEMCID	CID: 2719	
DRUG0010	HIGHSTAT	Withdrawn from market	
DRUG0010	HIGHDISE	Malaria	
			
DRUG0005	DRUGNAME	Streptokinase	
DRUG0005	DRUGTYPE	Protein/peptide drug	
DRUG0005	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0005	DRUGSTAT	Discontinue Drug in Phase 3 Clinical Trial	
DRUG0005	HIGHSTAT	Phase 4	
DRUG0005	HIGHDISE	Acute Myocardial Infarction	
			
DRUG0004	DRUGNAME	Alferon LDO	
DRUG0004	DRUGTYPE	Protein/peptide drug	
DRUG0004	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0004	DRUGSTAT	Discontinue Drug in Phase 2 Clinical Trial	
			
DRUG0001	DRUGNAME	VRC-SRSDNA015-00-VP vaccine	
DRUG0001	DRUGTYPE	Vaccine	
DRUG0001	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0001	DRUGSTAT	Discontinue Drug in Phase 1 Clinical Trial	
			
DRUG0002	DRUGNAME	SARS-CoV vaccine	
DRUG0002	DRUGTYPE	Vaccine	
DRUG0002	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0002	DRUGSTAT	Discontinue Drug in Phase 1 Clinical Trial	
			
DRUG0003	DRUGNAME	Recombinant S protein SARS vaccine	
DRUG0003	DRUGTYPE	Vaccine	
DRUG0003	DISEASES	Severe acute respiratory syndrome (SARS)	
DRUG0003	DRUGSTAT	Discontinue Drug in Phase 1 Clinical Trial	
